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The endocrine part of the mammalian pancreas" is composed of small 
clusters of ceils, the islets of Langerhans, irregularly distributed in the pancrea-
„.,„... .^>.„, . '^ ,„ ,„„^ .....„„. 
description of the pancreatic islets*by Paul Langerhans, our knowledge of their 
cellular compositfw is still incomplete. It ^appeairs that there are at least four 
types of cellular popufatieiia^Jjj^^the islets, each responsible for the synthesis, s to-
rage and release of its specific peptide hormone according to the need. Strict 
regulation of the release of these different types of pancreatic hormones is vital 
since the intricate balance of these hormones play a very important role in main-
taining a proper metabolic order in animals. 
Abnormalities in beta ceil s tructure and function may be ctioiogicaiiy 
inv-olved in the expression of diabetes mellitus. Many diverse abnormaliiies in 
beta cell integrities may result in a clinical syndrome characterized by carbuin -
drate intolerance. In the present studies, efforts have beep, inade to gain sojue 
knowledge on the changes in the beta-cell , due to age as i-idicated by the bsnclrig 
ol i ertain insulin secretagogues on the islets isolated iro;i diflerent age gro ips 
oi ra ts . The < orielation between the binding of insulin si- -etagogues ^nd the 
resulting islets activities have been studied. In addition, insulin releasing a in \ ;T\ 
of certain plant material as well as synthetic compounds have been described 
in this dissertation. The results and conclusion are summarized. 
6.1 Studies oo the factors affecting the diminished insulin release during aging, 
mediated by Agofiaa lasporus PH A-6 Icictin from islets of Laigerhans in 
vitro 
125 6.1.1 Effect of aRe on the binding of Meet in to islets of Lan^erhans in 
\itro 
The binding studies were carried out in vitro on the isolated islets of 
125 Langerhans. There was nearly three fold decrease in the binding of I-lectin 
in the case of islets from 12 months old rats as compared to that from one month 
old rats. Thus, the binding of the lectin in the case of the islets isolated from 
I, 3, 6 and 12 months old rats were 22.'fl ± 2.t>l, 17.12 ± 2.21, 11.80 ± 2.02 and 
7.51 ± 1.81 ng of lectin bound/i5 islets respectively, showing the age related 
changes on the beta-cell membrane effecting the binding of the lectin. 
125 
6.1.2 Effea of glucose on the binding of I-lectin (PHA-B) to the islets 
in vitro 
There was no significant change in the biTKfing of lectin to islets in the 
presence of increasing concentration of glucose in the medium indicating that 
the binding sites of glucose and the lectin might be different. 
6.1.3 Effect of the binding of PHA-B lectin on lysosomal enzv-mes 
While the Cathepsin-B activity increased significantly after the binding 
ol lectin to the islet in a dose dependent manner, there was no elfect of the 
lec'.in on the activity of acid phosphatase. The stimulation of caihcpsin-B by 
liferent insulin secretagogues have been shown by many workers which suggested 
the involvement of cathepsin-8 in the conversion of proinsulin to insulin. 
6.1.4 Effect of the lectin binding on the islet on protein kinase activity 
Age has been found to have no effect on the activity of protein kinase, 
neither has lectin (PHA-B) any effect on the activity of this enzyme indicating 
that protein kinase activity might not be involved in the changes in the islets 
due to age. 
6.1.5 {Effect of age on Agartcus bisporus PHA-B stimulated insulin release 
There was significant stimulation of insulin release with sub-optimeil glu-
cose concentration in the medium, when PHA-6 lectin was added. This stimula-
tion of insulin release constantly decreased with age. This confirmed the earlier 
findings and can be correlated with the corre^onding decreasing binding of the 
lectin to the islets with the increasing age of the animal. 
45 7* 
6.1.6 Effea of age on Agaricus bisporus PHl\-B stimulated Ca uptake 
45 2+ Like insulin release there was significant increase in the upt2J<e of Ca 
with sub-optimal glucose concentration when PHA-8 lectin was added in the 
45 2+ 
medium. The stimulation of Ca uptake with the lectin decreased constantly 
with the increasir^ age. This might also be the result of the binding of the lectin 
to the B-cell. 
14 
6.1.7 Effect of age on proinsulin/insulin content and C-leucine incorporation 
"imo the (pro>insulin in the isolated islets of Langerhans 
In the older age groups of rats (12 months) the content of proinsulin/insulin 
was found to be about two times higher than In case of one month old rat . 
However, the stimulation of proinsulin biosynthesis by the PHA-6 lectin was 
more than three times higher in the case of the islets from one month old rat 
than that of the 12 months old rats. The above observations were supported 
by the direct incorporation of C-leucine into proinsulin in vitro in the islets 
of both the groups of rats. It was found that there was two times more incor 
poration of C-4eucine in the case of islets isolated from one month old rats 
than in the case of islets of 12 months old rats after the stimulation by the 
lectin. 
6.1.8 Effect of age on the lectin (PHA-6) stimulated conversion of proinsulin 
to insulin 
Proinsulin and insulin of the islets were separated by sephadex G-50 fil-
tration. Proinsulin was characterized by its conversion to insulin by trypsin. 
Insulin was estimated by the radioimmunoassay, technique. PH A-8 lectin stimu-
lated the conversion of proinsulin to insulin quite significantly. It was found 
that age has a pronounced effect on the lectin mediated transformation of pro-
insulin. The conversion of proinsuiin to Insulin in the case of 12 months old 
rats was found to be about I'+'^ o less as compared to the conversion in the case 
of one month old rats. It was concluded that the conversion of proinsulin to 
insulin might be an important step in the release of insulin froin the islets. 
6 ^ Biocheniical studies on the hypoglycemic properties of Pterocarpus marsu-
jwon tboA. 
6.2.1 Effect of (-) Epicatechin on insulin release from the islets of Langerhans 
in vitro 
It was found that (-)epicatechin stimulates insulin secretion from isolated 
islets of Langerhans in a dose dependent manner quite significantly. (-) Epicate-
chin is the active principle of the water extract of the wood of Pterocarpus 
marsujriwn. The claim of hypoglycemic activity in the water extract of the 
wood was confirmed. 
6.2.2 Effect of (-)epicatechin on the activities of glucose-6-phosphatase and 
phosphofructokinase in islets of Langerhans in vitro 
Jn yntro stixlies on isolated islets of Langerhans showed that (-)epicatechin 
significantly diminished the activaty of glucose-6-phosphatase, while the activity 
of phosphofructokinase was significantly increased. These findings further suppor-
ted the hypoglycemic property of the wood extract. 
6.2.3 Effect of (-)epicatechin on C-leucine incorporation into (pro)insulin 
in islets of Langerhans in vitro 
The stimuiaticffi of proinsulin biosynthesis by (-)epicatechin was demons-
trated by the significant incorporation of C-leucine into proinsulin when the 
14 islets were incubated in vitro with (-)epicatechin. The incorporation of C-
Icutinc was found to be dependent on (-)epicatechin concentration in the medium. 
Cycioheximide was found to completely block the (-)epicatechin stimulated pro-
ms ilin biosynthesis in the islets. These observations furil->er support that the 
plant possesses the property of stimulating insulin bios>'nthesis. 
6.2.'f Studies on the hypoRlycemic properties of wood extract of Pterocarpus 
marsuuium Roxb« 
The feeding of ethyl acetate soluble fraction (XE) of alcoholic extract 
of Pterocarpus marsupium wood to alloxan induced diabetic rats was found to 
have a significant effect of lowering the fasting blood sugar level. Glucose 
tolerance test carried out on the alloxan diabetic rats which were fed with 
the wood extract showed a marked improvement in their blood glucose lowering 
capacity. These findings support the claim that the extract of Pterocarpus 
marsupium wood is effective for the control of diabetes mellitus. 
There was also significant increase in the insulin level of the blood in 
case of alloxan diabetic animals which were fed with the extract, compared 
to the control animals (alloxan diabetic without drug treatment). 
The stimulation of the incorporation of C-leucine into (pro)insulin fra-
ction in the case of XE fed animals, suggest that the extract XE is not only 
insuiinogenic but also stimulates th* biosynthesis of insulin. 
6.3 Effect of synthetic an^ogues of C-tenninal tetrapeptide amide of chole-
cystokinin OR in«iiiftn and ^ttcagsn retease from the islets of Langerhans 
in vitro 
C-terminal tetr.^>eptide an.de of cholecystokinin (CCK-'f) and eight 
of its synthetic analogues were te- '^.ed on isolated islets of Langerhans for their 
glucagon and insulin releasing acti . ty . Synthetic cholecystokinin (CCK-*>) was 
found to be highly active in releas ,^ both insulin and glucagon from the isolated 
islets of Langerhans- It was founc :o be active for the release of both the 
-10 hormones upto its concentration o: 10 M. The stimulauon of release of both 
the horm«ies by CCK-4 was found to be dose dependent. Eight analogues of 
CCK-it were tested for their effect on the release of insulin and glucagon. 
It was fouBd that the replacement of the first amino acid Trp by other aroma-
tic amino acids such as Phe or Tyr makes the compound ineffective for the 
release of both insulin or glucagon. However, the substitution of Trp at position 
one by pro or Glp does not effect much on their insulin releasing capacity. 
On the other hand, the glucagon releasing activity of these two analogues is 
almost completely lost. Replacement of methionine at position two by hydrop-
hobic amino acids (leucine) and hydrophilic amino acid (serine). The analogue 
with ieucme at position two had no effect on the release of two hormones. 
The other analogue with serine at'position two showed inhibitory effect on the 
release of both insulin and glucagon. Methylation of the internal amide bond 
between Asp-Phe resulted in the inhibition of both insulin and glucagon secre-
tion. Introduction of double modification in the CCK-'J molecule, i.e. the repla-
cement of Trp at position one by pro and the methylation of C-termineil amide, 
yielded a compound which stimulated insulin release and at the same time inhibits 
the release of glucagon in a dose dependent manner. 
Thus, it is clear that useful compound with clinical importance can be 
obtained from the CCK-^ f analogue for the development of drugs for the control 
of -.he type 11 diabetes mellitm. 
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PREFACE 
Pancreatic islets of Langerhans represent a unique cluster of d i f ferent 
types of cellular populations responsible for the biosynthesis and secretion of 
the i r character ist ic peptide hormones. A well knit del icate balance of these 
hormones is ext remely vital for the maintenance of various metabol ic regulations 
in the body especicilly the homeostasis of glucose. Thorough knowledge of the 
islets and its various cel l types is, there fore , a must for understanding the 
mechanisms through which a well balanced interact ion of various peptide ho r -
mones of the islets brings about this del icate and vi tal biological e f f ec t . Many 
factors, including genetic, age and obesity are known t o e f fec t the above hormo-
nal balance causing various metabol ic disorders including disturbance in the 
glucose homeostasis. Matur i t y onset diabetes mellitus is one of the major 
diseases in human population all over the wor ld. However, the exact mechanism 
of the age related changes in the B-cell functions are s t i l l obscure. 
Although immense progress has been made towards understanding the 
chemiccil nature and physiological importance of the most important hormone 
of the islets, i.e. insul in, i ts biosynthesis, storage and releeise are comparat ively 
new fields and biochemical investigations on them have only recent ly started 
gaining pace. 
Attempts have been made in the present investigations to gain some 
insight into the change in the B-cell due to the age of the animal . These changes 
are indicated by the age related binding of a insulinogenic lec t in on the cell 
membranes of the islets, decreased rate of conversion of proinsulin to insulin 
11 
and increased activity of certain lysosomal enzymes. In addition insulinogenic 
properties of some plant materials as well as synthetic C-terminal tetrapeptide 
of cholecystokinin (CCK-4) analogue, have been presented. 
The findings brings into light some very interesting tetrapeptide analogues 
to cholecystokinin (CCK-'J) which can selectively stimulate insulin release from 
the islets and inhibit at the same time the release of glucagon from the islets. 
These tetrapeptides and a plant material, (-)Epicatechin described in this disser-
tation are promising compounds to be explored, with the view to developing 
new oral drugs for the control of type II diabetes. 
I l l 
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AMP - Adenosine-5'-en onophosphate 
ADP - Adenosine-5'-diphosphate 
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1.0 REVIEW OF LITERATURE 
I.l The islets of langerhans 
The islets of langerhans of pancreas constitute the chief endocrine unit 
involved in the regulation of body's carbohydrate, protein and lipid fnetabolisn. 
The islets were first identified by Paul Langerha.is in 1869 as small masses of 
cells ("Zellhaufchen") scattered throughout the exocrine parenchyma of pancreas, 
but their functional significance remained unknovi/n for more th.an two decades. 
Meanwhile the classic experiments of Von Merring and Minkowski (1889) provided 
the first indication that the pancreas, as a whole, is in a way involved in the 
pathogenesis of diabetes mellitus. It was, however, Laguesse (1893) and Schaefer 
(1895) who suggested an endocrine function to the "Zellhaufchen" and their possible 
involvement in the development of diabetes mellitus. It was also Laguesse who 
naned the "Zellhaufchen" as islets of Langerhans("'d'ilot de Langerhans") after 
their discoverer. The islet tissue is also often described as "endocrine pancreas". 
A few years later. Lane (1907), working in Prof. R.R. Bensley's Laboratory, 
identified and differentiated two cell types in islets, the alpha and beta cell, by 
the preferential solubility of beta cell-granules in 70 per cent ethanol and the 
preservation of the granules in chrome sublimate fixative. Then, came the historic 
discovery, by Banting and Best in 1922 of the antidiabetic internal secretion -
'insulin' - in the acid - ethanol extracts of pancreas. 
The discovery of insulin, besides prolonging useful lives of .nniilions of diabe-
tics, has stiiTiulated further research on the morphology and function of not only 
the endocrine pancreas but also other endocrine organs. Today, however, the endo-
crine pancreas is still an enigma and is slowly emerging not merely as insulin-pro-
ducing cell mass but also as a co.nplex heterocellular endocrine organ capable 
of elaborating as many as nine biologically active substances/hormones: the func-
tional significcince of many of these substances is not as yet understood and is 
the subject of intense research. 
1.1.1 Moqjhology of islets of langerhans 
The endocrine pancreas of normal adult rat consists of approximately 2000 
islets of langerhans (Hellman, 1959c) with a mean diameter of 100 to 200 \ir\ 
(range: 50-300 \sx\) (Hellman et al., 1964; Henderson, 1%9; Zimmy and Blackard, 
1975). They are recognizable as spherical, ovoid, elliptical or irregular aggregates 
of cells dispersed throughout the pancreatic exocrine parenchyma with a slight 
preponderance in the tail (splenic) portion of pancreas. The islets are richly vas-
cularized and the constituent cell^;ypes, especially the beta cells, tend to be pola-
rized towards the capillaries. The total volume of the islet tissue in the adult 
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rat aged 100 days is about 1.75 mm (Hellm an, 1959b) which is about one per cent 
of the total pancreatic volume (Van Assche, 197^*). 
1.1.2 The islet cell types 
On the basis of tinctorial affinities and silver impregnation methods, three 
major cell-types, namely, cdpha (A. -or A_ -cell of Hellerstrom and Hellman, 
1960), beta (B-cell) and delta (D - or A. - cell of Hellerstrom and Hellman, 1960; 
Hellerstrom et al., 196^ )^ have been identified and described in the islets of a large 
number of vertebrates, including man (reviewed by Lange, 1973). 
In recent years, with the development of highly sensitive, specific and widely 
applicable immunohistochemical/immunofluorescent techniques, the islet cell4ype-; 
are recognized and differentiated more by the hormones they elaborate than by 
their affinities to stains and metals. This improved tnethodology not only provided 
the first definitive proof that the sources of insulin, glucagon and somatostatin 
are the beta cell, the alpha cell and the delta cell, respectively, but also identified 
a large number of biologically active substances and hormones, such as pancreatic 
polypeptide, gastrin, vasoactive intestinal polypeptide, calcitonin, enkephalin, neuro-
tensin, vasopressin, parathyroid-like homnone, adrenocorticotropin, cholecystokinin 
etc. within the islet cell population as reviewed by Ronald and Hubert (1983). 
Rat islets are of 'mantle' type ( =type 1 of Lange, 1973) where a large core 
of beta cells are surrounded by a peripheral rim (mantle) of other cell-types. 
In rat and man this mantle comprises of alpha, delta and the pancreatic-polypeptide 
(PP-) cells as well as a few beta cells and a small number of other cells whose 
products may be more than one of the substances mentioned above (Caramia, 1963; 
Grimelius, 1969; Lacy and Greider, 1972; Goldsmith et al., 1975; Ruefener et al., 
1975; Erlandsen et al., 1976; Sundler et al., 1977). The relative proportion of the 
different cell types in the islets may vary depending upon the part of pancreas 
(Orci et al., 1976; Van Assche et al., 1976) and whether or not the animal is dia-
betic (Van Assche et al., 1976; Mc Evoy and Hegre, 1977; Baetens et al., 1978). 
Orci and Unger (1975) advanced a dynamic functional interpretation to the 'mantle-
t ype ' organization of islet cel ls. These authors divided the islet into two funct ional 
sub-units: a peripheral 'heterocel lular ' region composed of alpha, beta and del ta 
cel ls, and a central 'homocel lular ' unit consisting main ly of beta cel ls. The he te -
rocel lular unit is considered funct ional ly more dynamic and involved in rapid moment 
to-moment regulation of the funct ion of constituent cel l types, while the homoce-
l lular unit is thought to provide the steady-state beta cel l func t ion . 
Islets of normcd rat pancreas grow w i th increasing age (Hel lman, 1959a,b) 
apparently by repl icat ion of fu l l y d i f ferent ia ted and granulated endocrine cells 
(Freytag, 1968; Logothetopoulos, 1972; Hel lerstrom et a l . , 1976; McEvoy, 1981). 
However, i t was demonstrated that the rate of m i t o t i c ac t i v i t y and the proport ion 
of the islet cells which show m i t o t i c ac t i v i t y are high only in new born animals 
and decrease w i th advancing age (Swenne, 1983); in adult islets a maximum of 
about only 3% of the cells show m i t o t i c ac t i v i t y . I t is hence evident that rep l ica-
b i l i t y of exist ing islet cells is insuff ic ient t o explain the increase in the volume 
of islets in adulthood. 
1.1.2.1 The Beta cell 
1.1.2.1.1 Morphology 
The beta cell is probably the single most extensively studied cell type of 
the islets d j e , obviously, to the importance of i ts secretory product , insul in. 
Using the d i f ferent staining methods the beta cells have been found to rep -
resent 60 to 80% of the to ta l islet cells (Hel lman, 1959a; Van Assche, 197^). An 
individual beta cel l has a mean diameter of 10 vfn and a mean volume of 875 vim 
which is about three t imes that of an alpha cell (Hel lman, 1959d). Using electron 
microscopy, the beta cells are recognized by their characteristic secretory granules. 
The granules consist of a crystcdline or a-norphous core enclosed in a membranous 
sac. In rat and many other species two main types of secretory granules, namely, 
the dark and pale granules have been identified. The dark granule contains highly 
electron-dense crystalline core which is separated from the membranous sac by 
a distinct and a broad electron-lucent matrix ceilled 'halo', whereas the pale granules 
show a less electron dense amorphous core and a very narrow 'halo' (Lacy, 1962; 
Like, 1967; Bencosme and Paloma, 1968; Howell et al., 1969; Goldenberg et al., 
1969). Other ultrastructural features that distinguish the beta cell from non-beta 
cells include the distinct rod-shaped mitochondria, a prominent Golgi complex and 
a less proiTiinent endoplasmic reticulum in the beta cell (Lacy, 1962; Hedeskov, 
1980). 
1.1.2.1.2 Functions 
It is now well established that the normal function of islet beta cell is 
synthesis, storage and release of the anabolic hormone, insulin. 
Insulin is a polypeptide with a molecular weight of 6,000 daltons and consists 
of two peptide chains, A and B, of 21 and 30 amino acid residues, respectively, 
(Fig. 1). The two chains are linked covalently by two interchain disulphide bridges; 
an additional intrachain disulphide bridge joins the 6th and 11th amino acids in 
the A chain. Within the beta granules, insulin exists mostly in polymeric form, 
the degree of polymerization being dependent on the physico-chemical environment 
of the beta ceil and on the zinc content of the granules. Insulins of different 
mcmmaiian species may show considerable variations in their amino-acid composi-
tion but are more or less identical in their biological activity. 
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Fig. 1. Structure of Human proinsulin showing sites of cleavage (dotted 
circles) by t ryps in . 
(Kemmler et a l . , 1972). 
Islets of la:,j^erhans play a very important role in regulating the metabolism 
of carbohydrate, proteins and lipids. The most common and well known syndrome 
originated from the malfunctioning of B-cells of the islets of langerhans is 
diabetes mellitus. It is one of the world's greatest health problem with an estima-
ted minimum of 'tO million people suffering from the disorder. In India, a develo-
ping country, the disease is almost as much prevalent (1.9%) as in most of the 
developed countries, the United States of America (2.0%) (Ajgaonkar, 1980). The 
disease is associated with three4imes higher mortality rate, three times higher 
frequency of heart disease, ten times higher frequency of blindness and gangrene, 
and amputations are necessitated twenty times more often in diabetics than in 
rest of the population (Brownlee and Cahill, 1979). 
Diabetes mellitus is primarily a disorder of carbohydrate metabolism. In 
normal subject the plasma glucose concentration is the result of two processes. 
The rate of endogenous glucose production/availability and the rate of glucose 
removal/utilization by tissues of the body. In fasting state the rates of the two 
processes are equal and the plasmic glucose concentration remains constant. In 
diabetes mellitus the rate of either or both the processes are abnormal and the 
result is increased plasma glucose concentration (hyperglycemia). Thus, diabetes 
mellitus may be defined, basically, as a state of chronic hyperglycemia due to 
impaired glucose tolerance. 
The two most important prevalent types of human diabetes are the insulin-
dependent (and Ketosis-prone) diabetes mellitus (IDDM or Type I; the erstwhile 
'Juvenile Diabetes') and the non-insulin dependent (non-ketosis prone) diabetes 
mellitus (NIDDM or Type II; the erstwhile maturity onset diabetes mellitus), of 
which NIDDM may be obese or non-obese. 
1.2 Pathogenesis and etiology of diabetes mellitus 
Inspite of the intensive research during the past several years, the pathoge-
nesis of IDDM and NIDDM remains largely unknown. 
NIDDM is the most common and the most heterogenous form of diabetes 
and about 80% of diabetic population belong to this category. NIDDM may be 
asymptomatic for years with only a slight progression and the onset of disease 
is often after the age of liO. 
In NIDDS the fasting plasma glucose is constantly elevated due to increa-
sed glucose release from the liver and a reduced peripheral clearance (De Fronzo 
et al., 1982; Kalant et al., 1982); the negative feedback mechanism between 
plasma glucose and the hepatic glucose release is also impaired (Felig and Wahren, 
1975). Abnormal insulin secretion and peripheral insulin resistance have both 
been inhplicated in this impaired glucose homeostasis. 
The defect in insulin secretion may include -(a) deficient insulin release 
in response to glucose as found in lean NIDDs (Seltzer et al., 1967), (b) secretion 
of abnormally large amounts of insulin as found in obese NIDDs (Berson and Yalow, 
1965; Cerasi and Luft, 1967; Beck-Nielsen, 198^ *) and in some cases, (c) secretion 
of structurally abnormal insulin ("insulin Wakayana"; Nanjo et al., 1986). However, 
it has not yet been resolved as to which of these abnormalities is the primary 
one in the development of NIDDM. 
Morphologically, the islets of lean NIDDs show a decrease in volume, 
reduction in the number of beta cells and deposition of anyloid (Warren et al., 
1966; Westermark and Wilander, 1978; Saito et al., 1980 a,b; Stefan et al., 1982; 
Rahier et al., 1983). A correlation was also found between some of these features 
and the extent of glucose intolerance (Saito et al., 1980 a,b). 
1.3.1 Biosynthesis of insulin 
Insulin is synthesized initially as preproinsulin on the rough endoplasmic 
reticuluiTi (RER) of B-cell (Patzelt et al., 1978). Insulin biosynthesis is initiated 
in response to specific stimuli such as a rise in extracellular glucose concentration. 
Glucose exerts a preferential stimulation of translation of proinsulin messenger 
R:NA during short term incubation (Permutt and Kipnis, 1972a). A long term 
exposure to glucose increases also the transcription of new mRNA (Permutt 
and Kipnis, 1972 b), which might be associated with increased amounts of rough 
endoplasmic reticulum as observed in cultu'ed islets (Anderson et al., 197^*). 
Glucose apparently stimulates proinsulin biosynthesis by allowing less competitive 
mRNA to be translated more efficiently (Lomedico and Saunders, 1977). 
A single chain precursor polypeptide molecule preproinsulin (Chan et al., 
1976; Permutt and Hountman, 1977) is synthesized by ribosomes into the cister-
nae of RER. Preproinsulin is then converted to proinsulin by the removal of 
pre-signal sequence in the cavities of RER. The molecule is then transferred 
to the Golgi apparatus via vesicles of RER (Orci, 197^ *; 1982; 1985) by an energy 
requiring'mechanism (Sharp et al., 1975). The Golgi complex is said to be invol-
ved in the initiation of proteolytic maturation of proinsulin to insulin (Orci, 197^1; 
Steiner et al., 1970, 1974, 1976). Using electron microscope autoradiography, 
Orci (1986) was able to show that trans Golgi cisternae and secretory granules 
of B-cells in their initial stage are coated with a protein named Clathrin. Expe-
rimental evidences suggest that the coated granules play a critical role in the 
conversion of proinsulin to insulin and maturation of proinsulin. 
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A simplified scheme of the molecular biology of insulin formation is shown 
in Figute 2. 
1.3.2 Transport ^id Maturation of Proinsulin 
After synthesis of proinsulin in the RER, the newly synthesized protein 
is transported to Golgi apparatus (Howell et al., 1969 and 197^ )^ and is localized 
specifically at the trans-pole of the Golgi. This energy requiring step (Howell, 
1972) has been described to occur along the smoothed surface endoplasmic reticulum 
budding off into microvesicles which convey the secretory products to Golgi 
complex (Orci et al., 1973). After 10-30 minutes, the newly formed oroinsulin 
reaches the Golgi tubules, which have been implicated in the formation of new 
secretory granules (Munger, 1958). 
Secretory vesicles emerge from the Golgi apparatus where the newly 
synthesized products are packaged into the granule case and surrounded by Golgi 
membranes. It is believed that the newly formed granules undergo a maturing 
process over the next '•5-150 minutes (Howell et al., 1969; Orci et al., 1973). 
Proinsulin can be sorted out from other RER-derived proteins (e.g. lysosomal 
enzymes) in the absence of proteolytic cleavage (Orci et al., 198't a). It is already 
known that the sorting out of lysosomal enzymes is based on the presence of 
specific receptors in Golgi membranes (Sly and Fischer, 1982; Brown and Farquhar, 
198^^ ; Geuze et al., 198^ *). Using immunobinding technique, Orci et al (198^ b) 
found that in B-cell proinsulin is associated with the inner aspect of Golgi mem-
branes, whereas in secretory granules the immuno-reactive sites are located 
over the granule's core. This suggests the presence of specific proinsulin binding 
sites at the Golgi level. Hence compatibility of the specific binding process 
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12 
of proinsulin with ultrastructural localization of clathrin in the Golgi stack cannot 
be ruled out. In 1985, Orci et al. employing anti-clathrin antibody (Louvarad 
et al., 1983) found that most of the clathrin immunoreactive sites were localized 
at the transpole of Golgi. At the plasma membrane level, receptor-mediated 
endocytosis is characterized by association of clathrin coat with the cytoplasmic 
leaflet of the membrane (Goldstein et al., 1979) and clathrin is thought to be 
involved in the internalization of membrane segments with clustered receptors 
(Pearse and Bretscher, 1981). In analogy of the plasma membrane, Orci (1986) 
proposed the clathrin coats on trans Golgi membranes as morphological markers 
of "receptor mediated" intracellular transport which supported their working 
hypothesis of a proinsulin receptor mechanism involved in the attachment of 
coated secretory granules. 
1.3.3 Regulation of Proinsulin exit from Golgi Stack 
It has been well established that elevation of glucose concentration in 
the islet environment causes an increase in the insulin secretion by triggering 
exocytosis of storage granules and stimulating the biosynthesis of the hormone. 
Orel (1986) has studied the rate of transit of proinsulin through Golgi apparatus 
as a function of glucose concentration of the incubating medium, using cyclo-
heximide to arrest the synthesis of new hormone. His findings indicate that 
in Golgi proinsulin immunoreactivity is markedly decreased when the islets were 
incubated in the presence of high glucose concentration, whereas the decrease 
was strikingly reduced when the islets were transferred to low glucose-containing 
medium at the time of inhibition of protein synthesis by cycloheximide. 
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Since it is known that conversion takes place only after the prohormone 
has left the Golgi stack, it therefore rules out the possibility of decrease in 
processing of the prohormone and indicate that the effect may be due to slowing 
down of the proinsulin transport out of the Golgi stack. Too l i t t le is known 
about the mechanism of protein transport through and out of the Golgi. Nothing 
definite can be said regarding the mode of action of glucose in accelerating 
this transport . However, the findings of Orci (1986) provides a firm evidence 
for an unexpected effect of this secretagogue on the intracellular transit of 
insulin polypeptides. 
1.3.'» Con^rsion of proinsulin to insulin 
The conversion process requires the activity of, probably, two proteolytic 
enzymes: trypsin-like enzyme and carboxypeptidase-B with pH-optima between 
5.4 and 6.5 (Kemmler et al . , 1972). However, no conclusive evidence could be 
obtained on the identity and source of these proteolytic enzymes. Nevertheless, 
these proteases .appeared to be localized in the granules and/or their membrane 
sacs. The cytochemical demonstration of these enzyme activities in the granules 
located in the immediate vicinity of actively packaging Golgi succuJes, indicates 
that the enzymes are probably Golgi derived (Smith, 1972). The granule-packaging 
succules of Golgi complex belong to the specialized GERL [ancronyin derived 
from the spatial relation of Golgi apparatus to endoplasmic reticulum and its 
apparent role in producing lysosoines (Novikoff et al. , 1975)]. Since acid hydro-
lases have been demonstrated in all the components of GERL as well as in secretory 
granules (Lazarus et al . , 1966; Orci e t al. , 1971; Novikoff et al . , 1975), the possi-
bility of secretory granule-acid hydrolases including the proteases, having a GERL 
origin cannot be ruled out. 
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To have an exact demarcation of the subcellular site of proinsuhn conver-
sion, Orci (1986) made two approaches. Use of monensin lonophore [which perturbs 
the function (and structure) of the Golgi (Tartakoff, 1983)] and substitution of 
arginine and lysine with their respective analogs canavanine and thialysine (Noe, 
1981; Halban, 1982), which renders the proinsuhn resistant to proteolytic cleavage. 
Arginine in position 31-32 and arginine and lysine in position 6'f-65 of the proinsu-
lin molecule are recognized and removed by the converting enzyme(s) to release 
insulin and C-peptide. Pulse chase experiment in the presence of monensin showed 
that radioactivity was accumulated in the clathrin coated Golgi cisternae and 
clathrin coated secretory granules, whereas mature non-coated secretory granules 
showed a level of radioactivity as compared to control. Moreover, ^^ 7% decrease 
m the radioactive insulin was observed at the end of 85-minute chase period 
under monensin treatment (Orci et al., 198'fc). Replacement of lysine and arginine 
by their respective analogs resulted into strongly labelled clathrin-coated granules 
and weakly labelled non-coated granules. Moreover, only 11% of radioactive 
products was detected as insulin, as compared to 78% in controls (Orci et al., 
198'fd). These observations indicate the impairment of proinsuhn conversion 
and accumulation of radioactive secretory products m a clathrin-coated Golgi 
related conpartment of the B-cell. Hence conversion of proinsuhn is linked to 
Its unperturbed passage through clathrin coated compartment and subsequent 
maturation of the latter into non-coated secretory granules. 
Employing nonoclonal antibodies against recombinant proinsuhn (Madsen 
et al., 1984); Orci et al. (1985) have been able to specifically localize promsuJin 
in the 6-cell using immunofluorescence and protein-A-gold technique. These 
workers were able to show that proinsuhn was mainly localized in the Golgi stacks 
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in the form of coated granules which was dependent on the concentration of 
glucose, whereas the non-coated granules showed a low intensity as evidenced 
by immunolabelling. Incubation of islets in a medium containing 16.7 mM glucose 
priorly incubated at 1.67 mM glucose concentration [below the threshold for stimu-
lation of insulin biosynthesis (Kaelin et al., 1978; Morris and Korner, 1970)] resul-
ted into the progressive increase in the proinsulin specific fluorescence. On the 
other hand, a progressive decrease in the fluorescence intensity when the islets 
were transferred from high to low glucose<ontaining medium, cyclohcximide 
was also used to block the protein biosynthesis. These experiments showed thdt 
intracellular transit of proinsulin and conversion are independent of protein syn-
thesis (Steiner et al., 1970, 197^ *, 1976) and that extensive con^rsion takes place 
in dathrin coated granules. To confirm whether Golgi stack itself was involved 
in conversion as previously assumed (Steiner et al., 1970, 1974, 1976; Howell, 
1972), Orci et al. (1986) used antimycin A, [which does not prevent conversion 
step if added etfter the hormone has reached the converting compartment 
(Steiner et al., 1970, 197^ *, 1976)] to block the transfer of proinsulin from Golgi 
stack to coated granules (an energy requiring step). The results indicated that 
dathrin-coated granules are the major and probably only subcellular site of pro-
insulin conversion to mature insulin and that Golgi stack was not involved in 
this process. This was further confirmed using monoclonal antibody against insu-
lin, which showed only 1% cross reactivity with proinsulin and Golgi stack 
(Orci, 1986). Maximum amount of immunoreactivity weis present in mature non-
coated granules. 
1.3.3 The intragranular pH 
Clathrin-coated vesicles undergo acidification in vitro (Forgac et al., 1983; 
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Stone et al., 1983). The intragranular pH has been estimated to be between 5 
and 6 (Hutton, 1982). Recently, Anderson et al. (198't) and Anderson and Pathak 
(1985) have shown that intracellular compartments with low pH can be visucilized 
by the help of dinitrophenol, (DNP) 3 -{2, k - dinitroanilino) - 3 amino - N -
methyl dipropylamine (DAMP). DAMP accumulates in the acidic compartments 
and can be detected by monoclonal anti-dinitrophenol antibody interaction as 
revealed by immunofluorescence. Using this probe, Orci (1986) found that Goigi 
stack was devoid of DNP immunoreactivity whereas moderate immunoreactivity 
was found in clathrin coated (proinsulin - rich) granules. It was, therefore, proposed 
that proinsulin exists from Golgi stack in a non-acidic pH, and that this compart-
ment gradually becomes acidic. Acidification is coordinated with the conversion 
of prolinsulin to insulin and shedding of the coat (Orci et al., 1986). The regula-
tion of the intragranulcir pH may be critical for processing of insulin precursors 
and also for terminating the activity of the proteolytic enzyme(s). 
1.3X Intracellular Transport of Insulin 
It is generally accepted that insulin (along with equimolar proportion of 
C-peptide) is released into the extracellular space by exocytosis of the secretory 
granules (or 'emiocytosis'; Orci, 197^ ;^ Lacy, 1975; Cerasi, 1975). Before the 
release, the storage secretory granule has been shown to be transported to the 
cell membrane by a system of contractile actin4ike microtubules (Lacy et al., 
1968; Malaisse et al., 1972a; Van Obberghen et al., 1975; Kern, 1975; Pipeleers 
et al., 1976). The secretory granules subsequently be close to the cell membrane 
and the granule sac soon fuses with the cell membrane which opens up to release 
the granule content into the extracellular space (Fig. 3). While the fusion of 
17 
BETA GRANULE FORMATION 
R.E.R 
PROINSULIN 
(S-S Bond 
formation) 
PROINSUL IN 
EMIOCYTOSIS 
(EXOCYTOSIS) 
AMINO ACIDS 
TRANSFER RNA 
ATP.GTP, Mg++ 
Enzymes 
ANTIMYCIN BLOCKS 
TRANSFER STEP 1 
energy dependent) 
TRANSFER STEP 2 
10- 20 Min 
...EARLY GRANULES 
PROGRESSIVE 
CONVERSION 
(f 1/2= '^ 1 hour) 
20 Min 
4-
30-120 Min 
t MEMBRANE 
• ) MATURE O I RECYCLING 
GRANULE S > ^ 
TRANSFER STEP3 
(Energy dependent 
C Q - M - dependent) 
SECRETED PRODUCTS 
NSULIN \ 
C-PEPTIDE^94V. 
PROINSULIN t f... 
INTERMEDIATEg"'''' 
Zn-*-f 
OTHERS? 
HOURS-DAYS 
Fig. 3. Beta granule formation. The t ime scale on the r ight hand side 
of the f igure indicates the t ime required for each of the m 
stages of biosynthesis. 
(Steiner, 1976). 
ajor 
18 
the granule sac with the cell membrane is supposed to be under control of the 
microfilamentous cell-web (Orci et al . , 1972). The fission (rupture) of the fused 
membranes apparently is mediated, as demonstrated recently by certain "chemi-
osmotic" changes (Hermans and Henquin, 1986\ The conformation and contraction 
of the microtubular and microfilamentous system as well as other secretion related 
cellular phenomena are apparently modulated by intracellular and transmembrane 
fluxes of calcium (Ca"^" )^ (Lacy et al. , 1968; Malaisse e t al. , 1972b; 1978; Flatt 
et al., 1980). 
After the release of their contents, the empty membranous sacs of sec re -
tory granules become pinched-off into the cytoplasm as pinocytic micro vesicles. 
These vesicles are either returned to the Golgi complex or fuse with lysosomes 
(Meda, 1978) and become degraded (Lacy, 1975). 
IA Working model for Insulin Release 
The model shown in Figure 4 describes the possible steps linking stimulus 
to the release of insulin. In beta cells, a specific glucoreceptor exists on plasma 
membrane which recognize and bind with D-glucose and preferentially complexes 
with the alpha anomer of D-glucose. As a result of this interaction, the adenyl 
cyclase system is activated and through an unknown mechanism the beta cell 
membrane becomes more permeable to calcium, resulting in the influx of ionic 
calcium into the cell. The resultant change in the ionic flux is associated with 
a change in membrane potential. The interaction of D-glucose with thereceptor 
may be inhibited by such agents as alloxan, which probably destroys the receptor 
or by activation of alpha adrenergic receptor with epinephrine. In beta cells, 
cAMP plays a modulating role of releasing bound calcium from the organelle. 
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This modulating effect of cAMP can enhance glucoseHnduced insulin release when 
agents such as glucagon can bind with the receptor and increases adenyl cyclase 
activity. The ionic calcium in association with other factors initiates a contrac-
tion of the microtubular microfilamentous system with a resultant displacement 
of columns of beta granules on to the cell surface, where they are released by 
emiocytosis. This immediate release of insulin would form the first phase of 
secretion. The second phase of release would be due to stored and newly formed 
granules becoming associated with the microtubular microfilamentous system, 
and released by emiocytosis. However, this mechanism may not be sufficient 
to explain the release of insulin in certain situations. A 'multiphase' insulm release 
process has, therefore, been proposed by Grodsky (1972a) to be operative during 
continuous stimulation of the beta cell (Figure 5). 
Although morphological evidences amply demonstrate emiocytosis as the 
major mode of insulin release,it was, however, found insufficient to explain certain 
quantitative and qualitative aspects of insulin release, even in basal conditions. 
An alternative mode of insulin release such as intracellular dissolution of granules 
in the hyaloplasm and subsequent diffusion of insulin into the extracellular space 
has been suggested by Fukuma (197^*). Such a mode of insulin release was desig-
nated as 'diacrine' secretion by Yokh et al. (1966). 
1.5 The alpha cell 
Using immunofluorescent and immunohistochemical techniques, Baum et 
al. (1962), Okadaet al. (1968) and Bussolati et al. (1971) provided the first defini-
tive proof, at the cellular level, for the alpha cell origin of glucagon. 
Ultrastructurally, the alpha cells are identified by their characteristic 
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Fig. 5. "Square wave pulse" of glucose. An increased glucose concentra-
tion elicits a latency period which is followed by a second prolon 
ged phase with a more gradual increase in the rate of insulin 
release. 
(Hedeskov, 1980). 
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highly electron-dense secretory granules. The dense core of the granule, unlike 
that in the beta-granule, is only rarely crystalline, spherical in shape and is sepa-
rated from the surrounding membrane sac by a relatively dense 'halo' (Herman 
et al. , 196^*). 
In most species, the alpha cells consti tute 20-30% of the total islet cells. 
Further, the proportion of the cells to rest of the cell types is relatively low 
in the head and body of the pancreas than in the tail (splenic) portion (Orci et 
al-, 1976). In size, the alpha cell is three t imes smaller than the beta cell (Hellman, 
1959d). 
Glucagon is a single-chain polypeptide consisting of 29 amino acids and 
has a molecular weight of S'tSS daltons. The peptide contains a relatively rare 
amino acid, tryptophan. Porcine, bovine, human, rat and rabbit glucagons are 
identical in their primary structure (Moody and Sundby, 1980). Similarities in 
structure as well as biological activities were also observed between glucagon 
(porcine) and several peptides of gastrointestinal t rac t such as secretin, vasoactive 
intestinal polypeptide (VIP) and gastric inhibitory polypeptide (GIP). Further, 
glucagon and another peptide of gastrointestinal t rac t 'gut glucagon like immuno-
reactivity ' (gut GLM or Glicentin) appear to be derived from a common precursor 
molecule (Moody and Sundby, 1980). 
In contrast t o the wealth of information available on the biosynthesis 
of insulin in beta cell, very little is known about the synthesis of glucagon in 
the alpha cell. This is obviously due to the fact that the alpha cells constitute 
a very small proportion of the islet cells and it is at present extremely difficult 
to isolate pure alpha cell population in sufficient numbers for in vitro studies. 
Relatively recently, Patzelt et al . (1980) have identified a 21 K-dalton and an 
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18 K-dalton mol. wt. peptides 'preproglucagon' and 'proglucagon' respectively 
in pulse-labelled rat islets, but the mode of conversion of the peptides into glu-
cagon IS still not known. 
1^ The delta cell 
The delta cell was first identified by Bloom (1931) as a distinct cell types 
of the islets. Hellerstrom and Hellman (1960) who devised a silver-impregnation 
method for its demonstration in islet sections called it as A.-cell. Munger et 
al. (1965) confirmed the distinct identify ot the cell4ype and Fujita (1968) sugg-
ested an endocrine function to it. The delta cell is the least abundant cell-type 
and accounts for about 5-10% of the islet cell population (Orci, 1977; Van Assche 
et al., 1980). The cells are situated in the 'mantle' of islets interspersed among 
the alpha cells. 
Using electron microscopic methodology the delta cell can be recognized 
by the low electron density of its secretory granules. The granules show an amor-
phous core around which the membrane-sac is closely applied with little electron 
luscent 'halo' between the membrane and core (Goldsmith et al., 1975). The 
delta cell is also distinguished by its cellular extensions which often protrude 
into the intercellular spaces between adjacent non-delta cells (Goldsmith et al., 
1975). 
Immunohistochemicai and immunofJuorescent evidences establish firmly 
that the peptide somatotropin (growth hormone) release-inhibiting factor (SRIF) 
or somatostatin originally identified and isolated from hypothalamic extracts 
by Brazeau et al. (1973), is also present in the pancreas of a large number of 
species and that the peptide is the najor ho-m one synthesized aid >ecreted by 
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the islet delta cells (Luft et al. , 197'f; Dubois, 1975; Hokfelt et al . , 1975; Polak 
et al. , 1975; Orci et al . , 1975). Further confirmation of somatostatin as the 
hormone of del ta cells was provided by the immunoelectron microscopic localiza-
tion of somatostatin in the secretory granules of the cells (Ruefener et al. , 1975; 
Goldsmith et al . , 1975; Pelletier and Leclerc, 1975). It was also soon found that 
in addition to its presence in islet delta cells and hypothalanus, somatostatin 
or so>Tiatostatin-lil<e immunoreactivity is also localized in distinct cells situated 
in other pa-ts of the central nervous system, in the gastro intestinal t ract and 
m the thyroid gland (Hokfelt et al. , 1975; Arimura et al. , 1975; Patel et al. , 1981; 
Vinik et al. , 1981). 
S'Dmatostatin is a 1.6 K-dalton te t radecapept ide with a single intra ~hain 
disulphide bridge (Patel et al., 1981; Vinik et al . , 1981) very litt le is known about 
the intracellular events involved in the biosynthesis of somatostatin and its subse-
quent release. Obviously, this is at tr ibutable, as in the case of alpha cell, to 
the lack of suitable methods for isolation of this very sparse celMype of islet, 
for m vitro studies. 
1.7 Agents Influencing Insulin Release 
The islets of langerhans have a unique property of being able to respond 
to sevetal physiological stimulus resulting into the release of stored hormone 
in a nodulated fashion. However, the exact mechanism governing this process 
IS poriy understood. The secretion of insulin by beta-cells of islets of langerhans 
is influenced by nutrients, viz. sugars, amino acids, fat ty acids and ketone bodies, 
hormones (glucagon and gastrin inhibitory polypeptide) cAMP, and its derivative 
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and by rnethylxanthines, the inhibitors of cAMP phosphodiesterase. Some of these 
compounds are called 'initiators' since they are fully competent to elicit the release 
of insulin. These are glucose, mannose, glyceraldehyde and some anino acids, 
e.g. leucine. Sane secretagogues only amplify the response of 'potentiator'. 
These include hormones, cAMP, methylxanthines; some sugars (e.g. fructose and 
N-acetyl glucosamine) and some amino acids (e.g. arginine). Some potentiators 
can be induced to act as initiators under special circumstances, e.g. theophylline 
and dibutyl cAMP. Table I shows certain carbohydrate potentiators, initiators 
and inhibotors to insuln release. 
1.7.1 Glucose 
The mechanism by which glucose induces insulin release fron beta cell 
is poorly understood-Current evidences indicate that glucose induces insulin rele-
ase either via a direct interaction with an as yet hypothetical 'glucoreceptor' 
of beta cell ("regulator-site" model; Fajans et al., 1971; Ashcroft, 1980), or via 
the metabolism of glucose in the beta cell ("substrate site" model; Coore and 
Raidle, 196'f a,b; Matschinsky and Ellerman, 1973; Malaisse et al., 1982). 
Although the controversy regarding the sufficiency of these models to 
explain the mode of glucose-induced insulin release is still continuing, valuable 
information was, however, generated in the course of these studies regarding 
the metabolic make up of the beta cell and its inplication in the beta cell func-
tion. Glycolysis, pentose phosphate shunt, sorbitol pathway, Krebs cycle, adenosine 
triphosphate (ATP) ge.neration and utilization redox systems, etc. have all been 
identified and studied in beta cells (Hellman et al., 1971; Matschinsky, 1972; Lange, 
1973;Verspohl et al.,1979; Malaisse et al., 1982). 
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TABLE I - Effect of carbohydrates and their derivatives on release of insulin by mouse 
islets 
Initiators Potentiators Inhibitors No effect 
Glucose 
M annose 
N -acet yJglucosam ine 
Inosine 
Glyceraldehyc]'? 
Dihydroxyacetone 
Glucosamine 
Fructose 
N -acet ylglucosam ine 
Sorbitol* 
L -Glycer aldehyde 
Mannoheptulose 
Glucosamine 
Pyruvate 
Mannoheptulose 
Glucosamine 
L-Glucose 
2-Deoxyglucose 
Galatose 
3-0-Methylglucose 
Gold thioglucose 
Ribose 
Ribitol 
Xylitol 
Unless otherwise stated, all carbohydrates are the D-stereoisomer. 
*Rat islets. 
Compiled from Data of Ashcroft et al. (1972, 1973); Capito and Hedeskov (1976); 
Malaisse et al. (197^+) and Williams and Ashcroft (1978). 
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According t o Cerasi (1975), two dist inct recognit ion sites for glucose give 
rise to the two posit ive inputs in the beta cel ls; in i t ia t ion of the signal for the 
f i r ing of f of insulin and potent ia t ion, that results in ampl i f icat ion of the f.)rmer 
ef fect of the sugar. The th i rd event negative feedback regulat ion l inked to its 
release, modulate the f ina l response of the pancreat ic islet (Figure 6). 
The relationship between the extracel lular glucose concentrat ion and the 
rate of insulin release is sigmoidal. As i l lustrated (Figure 7), glucose concentra-
t ions below approximately 3 m M do not influence the secretory ra te . The threshold 
concentrat ion is around 't m M . The largest increase in insulin secretion occurs 
between 'f and 17 m M of glucose, which means that the beta cells are acutely 
sensitive to small changes in the glucose concentrat ion wi th in the physiological 
range. At s; i l l higher glucose concentrat ion, the curve tends to reach a plateau. 
Ha l f maximal secretion rates required 8 mM glucose in mouse and 6 m M in rat 
(Ashcroft et a i . , 1972). 
Grodsky et a l . (1968) f i rs t demonstrated the biphasic insulin secretion in 
response to sudden increase in glucose concentrat ion ("square wave pulse" of 
glucose). An increased glucose concentration e l ic i ts a latency per iod, which returns 
more or less to the basal level wi th in 5-10 minutes. This f i rs t phase is fol lowed 
by a second prolonged phase wi th a more gradual increase in the rate of insulin 
release (Figure 7). A two compartment model has been proposed to explain this 
biphasic response (Grodsky et cd., 1969). According to this model a small compar t -
ment of insulin IS par t icu lar ly labile to glucose and other st imulants and the f i rst 
rapid phase of secretion is because of emptying of this labile compartment. The 
large compartment containing stored insulin is re lat ive ly stable, provides the small 
compartment wi th insulin and may also release insulin d i rect ly but at a much 
i 
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Fig. 6. Hypothet ical model for the B-cell recognit ion of glucose 
\as an in i t ia tor and as a potent ia tor . 
(Cerasi, 1975). 
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Fig. 7. The relationship between the extracel lular glucose concen-
t ra t ion and the rate of insulin release. 
(Ashcroft et a l . , 1972). 
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slower rate than the small compartment. This model was further extended by 
k inet ic studies (Grodsky, 1972 a, 1972 b). The mechanism of glucose4nduced 
insulin secretion has been reviewed by Hedeskov (1980). 
1.7.2 Cyclic AMP 
Malaisse et a l . (1967) showed that methylxanthines, theophyl l ine and c a f f e -
ine, both well inhibitors of cycl ic nucleic phosphodiesterases st imulates insulin 
secret ion. Cerasi and Luf t (1970) advanced a theory that glucose molecule s t i -
mulated the plasma membrane bound adenylate cyclase during hyperglycemia 
and the cAMP thus produced was assigned the role of intracel lular t r igger leading 
to insulin release via a chain of events. In other words, cAMP may indeed be 
mediat ing the glucose action to the site of insulin release (Charles et a l . , 19/""^). 
Hence agents which are known to increase the cAMP content in the beta cel ls, 
also enhance the secretion of insulin (Malaisse et a l . , 1967 and Lambert et a l . , 
1971). Elevation of cAMP in islets by glucose preferent ia l ly alpha-anomers of 
D-glucose has been demonstrated by Charles et a l . (1973), Gr i l l and Cerasi (197^^, 
1975). 
1.7.3 Amino Acids 
L-Arginine (Palmer et a l . , 1975), L-Leucine and L-Phenylalanine (Landgraf t , 
197^1) have been shown t o st imulate the release of insulin by d i f ferent mechanisms. 
L-Argin ine, the most potent amino acid of insulin release st imulates the release 
by d i rect ly e l ic i t ing glucagon from the alpha-cell (Mi lner, 1970). Non-metabo l i -
zable analogs of leucine and arginine st imulate insulin secret ion, which suggest 
that amino acids may tr igger islet hormone secretion via membrane receptor 
(Efendic et a i . , 1975). 
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1.7A Fatty Acids 
Octanoate, valerate, butyrate and propionate (short chain fatty acids), 
oleate and palmitate (long chain fatty acids), 3-hydroxy butyrate and acetoacetate 
(ketone bodies) stimulate insulin release from islets of various species in the pre-
sence of non-stimulatory concentration of glucose (Hawkins et al., 1971). 
S^yffert and Madison (1967) proposed that these agents may be important 
during starvation to ensure sufficient insulin release to prevent fatal ketoacidosis. 
1.7.5 Hormonal Influences 
Glucagon stimulates secretion of insulin directly by acting on beta-cells 
and indirectly by producing hyperglycemia (Curry, 1570). The stimulation of insu-
lin by glucagon is in a dose related manner^ (Samols et al., 1965; Turner and Mc 
Intyre, 1966; Ketterer et al., 1967) of the hypothalamic hormones, only somatos-
tatin effects insulin secretion (Weir et al., 1974). Insulm release is inhibited by 
somatostatin (Alberti et al., 1973; Efendic et al., 1974; Gerich et al., 1975; Rizza 
et al., 1980; Kanatsuka et al., 1984). Growth hormone ACTH and TSH affect 
islet cell function hut hormones result in elevated basal and stimulated levels 
of insulin (Wise et al., 1973). Serotonin and dopamine occur in islets of several 
species (Lebovitz and Feldman, 1973 and Lundquist, 1971) suggesting that these 
amines may influence islet function. Dopamine has been reported to diminish 
insulin release (Rossini and Buse, 1973). Prostaglandin (PGE, and PGE^) augment 
insulin release to glucose in vitro (Johnson et al., 1973) either by direct (cAMP 
mediated) or by indirect means (release of catecholamines). 
Various vasoactive hormones have been reported to alter insulin release. 
Angiotensin, a vasoconstrictor diminishes release, whereas histamines, Kallikein 
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and bradykinin, all vasodilators, augment insulin release in vivo. It is doubtful 
that they affect islet functions significantly (Grodsky e t al . , 1968). 
1.7^ Neural Influences 
Insulin secretion is directly influenced by the central nervous system, Woods 
and Porte in 197^ * showed that sympathetic and parasympathetic nervous system 
may be modulators of alpha and beta-cell of islets of langerhans. Some hormonal 
peptides such as gut hormones, gastrin and cholecystokinin play important roles 
as neuroregulators. These are located in central (Dockray, 1976; Larsson and 
Rehfeld, 1977; Mueler e t al . , 1977; Rehfeld, 1978a, 1978b; Larsson and Rehfeld, 
1979) and peripheral nerves (Unvas-wallensten e t al. , 1977; Larsson and Rehfeld, 
1979). They are synthesized in neuronal tissue (Goltermann et al . , 1980). Their 
major physiological influences are probably indirect (Van Lane et al . , 1974 and 
Schatz et al. , 1973). Alterat^ion in insulin secretion can occur in spontaneous 
hyper (Maracek and Feldmap 1973) and hypothyroidism (Renould et al. , 197'f). 
Gastrin, secretin and pancreozymin {gastro intestinal hormones) have been 
implicated in explaining the observation that glucose or amino acid cause great 
insulin response when given orally and when given intravenously (Dupre et al. , 
1969). Insulin responses to meals where more likely mediated by peptide as yet 
incompletely characterized effect; these include enteroglucagon (Sasaki et al. , 
1974) vasoactive intestinal peptide (Said, 1974), gastric inhibitory polypeptide 
(Brown, 1974) and insulin releasing peptide (Creutzfeldt, 1974). 
Changes in insulin secretion occur during pregnancy (Saudek et al. , 1975), 
the estrous cycle (Bailey and Matty, 1972) and after the administration of oral 
contraceptives (Spellacy et al . , 1972). Progesterone administration elevates basal 
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insulin level and insulin response to glucose (Kalkhoff e t a l . , 1970). Estrogen 
(Speilacy et a l . , 1972) and testosterone (Bailey and Ma t t y , 1972) does not affect 
islet funct ion. 
Glucocort icoids have no e f fec t on in vitro islet cel l funct ion but prolonged 
exposure to these are concentrated in synaptic vesicles from where they are re lea-
sed l ike other neurotransmit ters (Emson et a l . , 1980). 
CCK nerve terminals are present in pancreat ic islets (Larsson and Rehfeld, 
1979). It seems that C4ermina l tetrapept ide amide Trp-Met-Asp-Phe-NH _ is 
predominant form of CCK in these nerves. It is referred to as CCK-^t and is 
common to both CCK and gastr in. Rehfeld (1971) studied the e f fec t of various 
cholecystokinins and gastrin and found that CCK-^f was more e f fec t ive in releasing 
insulin in man and in mammals (Rehfeld et a l . , 1980). He fur ther observed that 
the tetrapept ide amide hcis a neural control on secretion of insulin and other 
islet hormones (Rehfeld e t a l . , 1980). CCK is s t ructura l ly and funct ional ly related 
to gastrin and perhaps has a common evolut ionary origin (Larsson and Rehfeld, 
1977). Biological ac t i v i t y of this peptide is due to C^e rm ina l sequence and the 
remaining part mod i fy their potency on various target tissues. On studying the 
ef fect of d i f ferent forms of CCK on insulin release, Rehfeld et a l . (1980) found 
that all of them st imulate the secretion of pancreat ic hormones and that C C K -
4 was the most e f fec t ive one. It was e f fec t ive even at a d i lu t ion of 10 M. The 
intact tetrapept ide amide wi th free Trp and Phe-NH^ te rm in i seemed necessary 
for biological ac t i v i t y . Therefore, some peptides wi th certa in modif icat ions were 
synthesized, such as removal of Trp (CCK-3), extension of glycine (CCK-3), gastrin 
pentapeptide or by BOC-6-alanine (peptavlon) great ly reduced the secretagogue 
ac t i v i t y , C-terminal modi f ica t ion also reduced the potency, but deaminated 
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tetrapeptide Trp-Met-Asp4*he-OH stimulates insulin secretion at the highest con-
centration 10 M (Rehfeld et al., 1980). CCK-8 may act in islets via receptor 
linked phosphoinositide (PPI) hydrolysis leading to an inositol triphosphate induced 
Ca^ efflux. These receptor mediated effects of CCK-8 are not altered either 
by ambient glucose concentrations or the cAMP content of the islets, but these 
two factors determine the responsiveness of the islets (in terms of insulin secre-
tion) to a given CCK-8 signal (Zawalich et al., 1987). 
Two peptides analogous to the C-terminal tetrapeptide amide of CCK-^ 
(Glp-Met-Asp-Phe-NH-), Pro-Met-Asp-Phe-NH^) exhibit significant insulin releasing 
-8 -7 
activity at 10 M and 10 M concentrations (Ahmad et al., 198^ )^. 
1.7.7 Effect of Lectins 
Plant lectins are proteins that bind to specific carbohydrate groups on 
the plasma membranes of mammalian cells exhibiting a variety of biologic effects. 
Nowell (1960) observed the blast formation of lymphocytes by lectins, whereas 
they induce the release reaction in platelets (Majerus and Brodie, 1972) and produce 
a number of insulin like effects in isolated fat cells (Cuatrecasas and Tell, 1973; 
Czech and Lynn, 1973). Table II shows some of the biological effect of certain 
lectins. The precise mechanism by which lectins interact with plasma membrane 
is still unknown, however, they can be employed as useful probes for elucidation 
of the structural and functional characteristic of mammalian cell. Lectins from 
Agaricus bisporus and Agaricus capestris stimulate insulin and glucagon release 
in the presence of sub-stimulatory dose of glucose (2 mM) (Ewart et al., 1975). 
Ahmad et al. (198'fa) observed that there is enhanced uptake of calcium 
by isolated islets of langerhans when exposed to A. bisporus (PHA-B) lectin and 
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that the insulin release and calcium uptake decreases with the advancement of 
age (Ahmad e t al . , 198^^6). Although the basal insulin release and calcium uptake 
by islets remain unaffected by the age of the animal. 
1.8 Calciim and Calmodulin in Insulin Release 
Calcium plays an important regulatory role in insulin secretion (Wollheim 
and Sharp, 1981; Prentki and Wollheim, 1984). Glucose and secretagogues are 
incapable of eliciting insulin release in the absence of extracellular Ca (Hughes 
et al . , 1987). Stimulation of insulin secretion not only by glucose but by several 
other secretagogues, depends upon the presence of extracellular Ca (Curry et 
al . , 1968; Grodsky and Benette, 1966; Milner and Hales, 1967). Glucose increase 
the calcium uptake (Wollheim and Sharp, 1981; Hellman, 1985; Hellman et al. , 
1986) and also mobilize Ca from intracellular stores (Wollheim and Sharp, 1981; 
Prentki and Wollheim, 198^^). This occurs during prolonged stimulation (Siegel 
et al. , 1983) and the most likely site of accumulation would be mitochondria 
(Biden et al. , 1986). According to Gylfe and Hellman (1986), glucose promotes 
net uptake of Ca in endoplasmic reticulum (ER) of cells. This hypothesis has 
been further supported by the findings of various other workers (Rorsman et al. , 
198't; Hellman, 1985; Gylfe and Hellman, 1986; Gylfe et al. , 1983). Stimulation 
of Ca uptake by glucose results into the net increase in the islet calcium con-
tent as judged by chemical (Malaisse et al. , 1978), radioisotopic (Malaisse-Lagae 
and Malaisse, 1971) or ultrastructural cri teria (Ravazzola et al . , 1976; Schafer 
and Kloppel, 197^^). 
In order to understand the exact role of Ca '^ , two recently developed 
approaches have been made . D i r ea measurement of cytosolic Ca ^ concentrations 
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( [Ca ] i ) in small cells with fluorescent indicators and assessment of calcium 
transport by intracellular organelles (Prentki and Wollheim, 198'*). Since neither 
3-ceIIs, Wollheim and Biden (1986) have used cloned insulin secreting cell line 
RIN m5F, from rat insulinomas. This cell does not recognize sugar as a secreta-
gogue (Halban et al., 1983), however, it responds to triose glyceraldehyde which 
mimicks most of the action of glucose in pancreatic islets (Wollheim and Pozzan, 
198£f; Dunne et al., 1986). 
For many years, it was thought that mitochondria played the predominant 
role in the regulation of calcium in the cell, recent evidences using intact (Somlyo 
et al., 1985; Eisen cind Reynolds, 1985) and broken cell preparations (Becker et 
ai., 1980; Streb and Shulz, 1983) strongly suggests that endoplasmic reticulum 
(ER) is the organelle chiefly responsible for intracellular Ca regulation. 
It was reported by Sugden et al. (1979) and Valverde et al. (1979) that 
islets contained a calcium-dependent regulatory protein known as calmoduhn. 
They have suggested that the accumulation of Ca '*^  m islet cells may in turn 
affect enzyme systems susceptible to regulation by calmodulin. However, much 
work remains to be performed to scrutinize, in the islets, the effect of calmodulin 
upon such enzymes as cyclic AMP and cyclic GMP, phosphodiesterases, Ca ^ acti-
vated ATPase, and protein kinases, in order to assess the role of calmodulin in 
insulin release-So far it has been found that calmodulin binds to a subcellular 
particulate fraction derived from the islets and activates adenylate cyclase m 
the same fraction (Valvarde et al., 1979). Both the binding and activation phe-
nomena are modulated by the concentration of ionized Ca ^ in the 10" - 10 M 
range. These data provide a possible explanation for the capacity of several 
insulin secretagogues, known to cause calcium accumulation in islet cells, to 
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increase the production or content of cyclic AMP in these cells (Hellman et al., 
197'f). The km of adenylate cyclase for calmodulin is far below the actual con-
centration of calmodulin in islet cells. These findings are in good agreement 
with the view that the cytosolic concentration of Ca , rather than that of calmo-
dulin, represents the rate limiting factor in the activation of adenylate cyclase 
by the Ca -dependent regulatory protein. Cyclic AMP is known to enhance insu-
lin release evoked by a variety of secretagogues (Malaisse et al., 1967). This 
effect is apparently due, in part at least to an intracellular redistribution of cal-
cium leading to the cytosolic accumulation of this cation (Brisson et al., 1972; 
Sehlin, 1976; Sugden and Ashcroft, 1978). The interaction among Ca ^, calmodu-
lin,adenylate cyclase and cAMP is thus well suited to provide amplification of 
the secretory response to a given stimulus. 
1.9 Aging ^id Insulin Release 
The hyperglycemia of aging, which is frequent in older human populations, 
is of importance because it is a risk factor in coronary artery disease and because 
of its close relationship to the development'of maturity onset diabetes mellitus 
(Nilsson et al., 196^ ;^ Report of a Working Party, 1963; Joffe et al., 1969; O'Sullivan 
et al., 1971; Epstein, 1967). The possible causes of this hyperglycemia of aging 
include (i) altered insulin biosynthesis and release, (ii) altered insulin sensitivity 
and altered insulin action. Recently, studies on an animal model of aging, the 
older rats, have shown that there is diminished glucose stimulated insulin release 
from isolated pancreatic islets of langerhans of the older animals as compared 
with younger controls (Coddling et al., 1975; Kitahara and Adelman, 1979; Reaven 
et al., 1979; Lipson et al., 1981a; Reaven and Reaven, 1980; Gold et al., 1981), 
despite the fact that the (i) size of the islet, (ii) the number of beta cells per 
islet, (iii) number of secretory granules per beta-cell increases with increasing 
age and (iv) in aging, the proportion of beta cells per islet does not change (Reaven 
et al., 1979). However, this does not necessarily mean that the beta cell function 
is normal. To date studies to determine the biochemical changes in the islets 
responsible for the diminished glucose-stimulated insulin release have shown (i) 
altered islets adenylate cyclase system (Lipson et al., 1981 a,b). (ii) decreased 
glucose oxidation in older rats compared to younger ones (Reaven and Reaven, 
1980), (iii) progressive decline in the ratio of proinsulin to insulin in beta cells 
with age, and (iv) altered biosynthesis of the hormone (Gold et al., 1981). 
Adenylate cyclase-cyclic AMP system of beta-cells and glucose metabolism 
play a significant role in regulating glucose-stimulated insulin release. In older 
animals there is upto 60% decrease in the basal adenylate cyclase activity whereas 
there is no change in the activity of the low and high km phosphodiesterase and 
protein kinase with the age of the animal. Despite mtensive research work in 
this direction the exact mechanism underlying the age related hyperglycemia 
is still unresolved. 
2.0 INTRODUCTION 
kO 
2.1 Studies on the factors affecting the diminished insulin release during aging, 
mediated by Agaricus Msporus PH A-B lectin from islets of Langerhans in 
vitro 
The higher incidence of hyperglycaemia in aging human populations is 
well known (Nilsson et al . , 196'f; Hayner et al . , 1965; O'Sullivan et al. , 1971; 
3offe et al. , 1969). This age related hyperglycaemia has significant clinical 
importance since it is closely related to the development of matur i ty onset diabetes 
mellitus and is a risk factor in atherosclerosis (Epstein, 1967). Possible causes 
of age related hyperglycaemia may be attributed to (i) altered insulin secretion 
from the beta cells or (u) altered insulin action on target organs. Clinical human 
studies and in vivo animeil studies have not been in agreement as to whether insulin 
release is altered to glucose stimulation in aging (Andres et a l . , 1970; Berdanier 
et al. , 1971; Nolan et al. , 1973; Dudl and Ensinck, 1977; Soerjodibroto et al. , 
1979; Davidson, 1979) and the resulting uncertainty is still not resolved. Investi-
gations using isolated islets of Langerhans from aging rats have shown that there 
IS a diminished glucose-stimulated insulin release from them compared to the 
islets isolated from younger ones (Coddling et al. , 1975; Gold et al. , 1976; Kitahara 
and Adelman, 1979; Reaven et al. , 1979). To date , studies to determine the bio-
chemical changes in the islet, of older ra ts , responsible for the diminished glucose-
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stimulated insulin release, have shown cdteration in islet glucose utilization 
(Reaven and Reaven, 1980) and in islet insulin biosynthesis (Gold et al., 1981). 
But still the causes for the observed aging-induced secretory defect have not 
yet been fully elucidated. 
The stimulation of insulin release from the islets by a lectin has been 
reported by Ewart et al. (1975). This lectin, isolated from Agaricus bisporus, 
binds on the islet cell membranes releasing insulin and glucagon. Ahmad et al. 
(i98'fa) have demonstrated that A. bisporus PHA-B stimulated insulin release 
45 2+ is associated with Ca uptake by islets of langerhans and that the release 
[^ 5 2+ 
of insulin and the corresponding uptake of Ca decreases with increasing age 
(Ahmad et al., 198'tb). These authors suggested that this age regulated defect 
may lie at the level of membrane of the beta cells of the islets of langerhans. 
In continuation of these studies, we have investigated the possible age 
related changes in the beta cell membrane. Apart from lectin-stimulated insulin 
k5 2+ 
release and Ca uptake by islets, the studies have been carried out on the 
changes in the islets respectively, towards the lectin as manifested by the changes 
in the islets content of proinsulin/insulin, (pro) insulin biosynthesis, activities 
of cathepsin-B and acid phosphatase, conversion of proinsulin to insulin and 
125 finally the binding of I-labelled lectin to the islets during aging and under 
various glucose challenge. 
2.2 Biochemical studies on the hypoglycemic properties of Pterocarpus 
marsupium Roxb 
Herbs and plant extracts have traditionally been used for the control of 
diabetes mellitus in folk medicine all over the world. The bark of Pterocarpus 
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marsupium Roxb has been used successfully in Indian medicine for the treatment 
of diabetes. Chakrawarthy et al. (1980) reported that a flavanoid fraction (XE) 
extracted from the bark of Pterocarpus marsupium Roxb (Leguminoceae) effec-
tively reversed the alloxan induced changes in hyperglycemia and beta-cell popu-
lation in the pancreas and that it has protective effect when given prior to alloxan 
administration. Later, the active antidiabetic agent of the plant, was suggested 
to be (-) Epicatchin, a benzopyran (Sawhney and Sheshadri, 1956; Devon and Scott, 
1975). Chakrawarthy et al. (1980) reported that this compound brings about nor-
malization of blood glucose levels and promotes beta cell regeneration in islets 
of alloxan4reated rats. Recently, Charles and Simon (198'f) working on (-) Epica-
techin have reported that this compound increases insulin secretion from the 
islets in vitro and also raises the islet insulin content. Furthermore, islets of 
adult rats cultured in the presence of this compound showed a significant increase 
in DNA synthesis. 
In the light of these findings we have carried out in vivo and in vitro 
studies on this plant extract. The in vivo,experiments were carried out on alloxan 
diabetic model treated with the plant extract. Fasting blood sugar, oral glucose 
tolerance test, serum insulin levels and (pro)insulin biosynthesis were studied in 
the islets of normal, alloxan diabetic and (-) epicatechin treated rats. The in 
vitro experiments were carried out employing pure (-) Epicatechin and its effects 
on insulin release, (pro) insulin biosynthesis and on two enzymes of glucose meta-
bolism, namely, glucose-6-phosphatase and phosphofructokinase were studied. 
2.3 Structure activity relationship of CCK-^ ^ and its dialogues wsith respect 
to insulin and glucagon release from the islets of laigerhans in vitro 
Cholecystokinin, a gastrointestinal hormone has been implicated as neuro-
transmitter influencing insulin release from the islets. Rehfeld et al. (1980) 
t^3 
studied the molecular nature of CCK in peripheral nerves and observed that 
CCK-nerve terminals are present in the pancreat ic islets. The prominent form 
of CCK in these nerves seems to be the C^erminal te t rapept ide amide, Trp-Met-
Asp-Phe-NH- of cholecystokinin referred to as CCK-'f. It was observed that 
amongst various cholecystokinins, CCK-'f was considerably more effective in re lea-
sing islet hormones. 
With a view to designing highly potent congeners of CCK-'t that may se lec-
tivelly stimulate the secretion of insulin, without stimulating the secretion of other 
islet hormones. We have carried out s tructure-act ivi ty relationship studies of 
C-terminal tetrapeptide amide of cholecystokinin (CCK-4). These studies were 
carried out on the basis of side chain functionalities of the constituent amino 
acids. Ahmad e t al . (198^) have shown that insulin releasing activity is retained 
when the N t e r m i n u s Trp residue of CCK-'t is replaced by cyclic amino acid 
Glp or Pro. 
In conclusion of these studies, the insulinotropic effect of six different 
analogues in which modifications were introduced at position 1st, 2nd and 4th 
of the parent molecule, were studied with the view of getting some information 
regarding the role of side chain functions in the expression of their biological 
activity. Apart from this, it has been shown that the two insulinogenic analogues 
reported by Ahmad et al . (1984) have no effect on the release of glucagon (Khaiid 
et al. , 1986). 
CCK-4 and its following analogues have been studied. Structural details 
have been given in Figures 8, 9, 10, 11, 12 and 13. 
CCK-4 Trp ^Vlet-Asp-Phe-NH 2 
1 A Pro-Met-Asp-Phe-NH-
t*l^• 
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CHp 0 
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CHp 
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I II 
CHp 0 
I 
COO" 
II 
C-Terminal tetrapeptide amide of cholecystokinin 
[CCK-4] 
Fig. 8. Structure of Cterminal tetrapeptide amide of cholecystokinin (CCK-4). 
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II A Glp-Met-Asp-Phe-NH2 
I Phe-Met-Asp^Phe-NH2 
U Tyr-Met-Asp-Phe-NH-
III Trp-Leu-Asp4»he-NH2 
IV Trp -Ser -Asp -Me - Phe 
V Trp -Met -Asp -Me - Phe 
VI Pro^Vlet-Asp-Phe-NHCH^ 
In the case of lA and IIA (Figure 9), Trp has been replaced by pro and Glp, and 
in peptide I and II. Trp has been replaced by Phe and Tyr respectively (Figure 
10) in order to see the effect of five and six membered ring in the side chain 
of Trp, on the biological activity of the te t rapept ide . 
In peptide number III (Figure U) and IV (Figure 12) Met at position 2 has 
been replaced by Leu and Ser, respectively, in order to increase the hydrophobicity 
or hydrophilicity of the corresponding molecule. Finally, in order to make the 
molecule more resistant to carboxypeptidases, C-4erminal residue Phe has been 
either replaced by Me-Phe (peptide IV and V, Figure 12) or derivatized as amides 
(peptide VI,Figure 13). 
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Trp replaced by Glp at position 1. (Ptptide IA) 
HpN —C C —N—C C—N—C C—N—C C—NHp 
^ 1 1 II I II I II I II *-
HgC CH2 0 CH2 0 CH2 0 CH2 0 
I 
5 
CH3 
Trp replaced by Pro at position 1. (Peptide IIA) 
Fig. 9. (i) Structure of peptide IA. Trp at position 1st of the parent 
tetrapeptide is replaced by pro. 
(ii) Structure of peptide IIA. Trp at position 1st of the parent 
tetrapeptide is replaced by Glp. 
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I II I II 1 II I II ^ 
CH2 0 CH2 0 CH2 0 CH2 0 
CH3 
Peptide I 
[T rp replaced by Phe a t position I ] 
C—N—C-^—C N — C C—NHp 
II I II I 11 
0 CHp 0 CHp 0 
coo'=' 
Peptide n 
[Trp replaced by Tyr at positionl] 
Fig. 10. (i) Structure of peptide I. Trp at position 1st of the parent te t ra-
peptide is replaced bV Phe. 
(ii) Structure of peptide 11. Trp at position 1st of the parent te t ra-
peptide is replaced by Tyr. 
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C—N—C C—NHp 
II I II "^  
0 CH2 0 
Peptide I H 
[Met replaced by leu at position2] 
Fig. 11. Structure of peptide 111. Met at position 2nd of the parent 
tetrapeptide is replaced by Leu. 
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Peptide IZ 
[Met replaced by 5er at position 2&N-methylation at c-terminal] 
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Peptide 2 
[N-methylation a t c - te rm ina l ] 
Fig. 12. (i) Structure of peptide IV. Met at position 2nd of the parent te t ra-
peptide is replaced by Ser and C terminal is N-fn ethyl at ed. 
(ii) Structure of peptide V. The parent tetrapeptide is N-methylated 
at C^ermincil. 
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Peptide V I 
Trp replaced by Pro and C-terminal amide Substituted by 
Methyl group 
Fig. 13. Structure of peptide VI. Trp at position 1st of the parent 
tetrapeptide is replaced by pro and Cterminal amide is 
substituted by methyl group'. 
3.0 MATERIALS AND MEJt^ODS 
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3.1 Materials 
Golden white mushroom (Agaricus bisporus) was obtained from National 
Botaniccd Research Institute, Lucknow, India. Sepharose 4B, Sephadex G-50 was 
purchased from Pharmacia Fine Chemicals, Uppsala, Sweden. Bovine serum albu-
min (BSA), Collagenase Type V, Aprotinin (Trasylol), a-Methyl-D-Glucoside, (-) 
Epicatechin, Alloxan monohydrate, chloramine-T, concanavalin A, Trypsin, Hist one 
type II a, a-Glycerol phosphate dehydrogenase, Triose phosphate isomerase and 
Aldolase were procured from Sigma Chemical Co., St. Louis, U.S.A. Amino acid 
kit, D-Mannose, PPO and POPOP were product of Sisco Research Laboratories, 
Bombay. Bovine Zinc insulin (6 times crysteillized) were obtained from Boots 
Drug House, Bombay. C-Leucine (sp. activity 208 m Ci/m mole), [y- p] ATP, 
Ca ^ (sp. activity U.O mCi/g) and Insulin radioimmunoassay kit was purchased 
from Bhabha Atomic Research Centre, Bombay, India. Glucagon radioimmuno-
assay kit was obtained from Serono Diagnostic S.A. 1267 Coinsins, Switzerland. 
C-terminal tetrapeptide amide of cholecystokinin (CCK-'f) and its synthetic analogues 
were synthesized in the Biopolymers Division of Central Drug Research Institute, 
Lucknow, India. All other reagents and chemicals used were of Analytical grade 
(AR). 
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3.2 Animals 
Animals used in the present studies were derived from animal colony of 
Central Drug Research Institute, Lucknow, housed in ciir-conditioned rooms. Charles 
Foster albino male rats maintained on standard balanced pellet (Hindustan Lever, 
Bombay, India) and water ad libitum were used throughout the experiments. 
3.3 Methods 
3.3.1 Isolation and purification of Agaricus bisporus lectins 
3.3.1.1 Extraction of Lectins 
A. bisporus lectins were purified according to the method of Ahmad et 
al. (198'tc). Golden white Agaricus bisporus mushroom were homogenized in normal 
saline (0.9% NaCl w/v) in a waring blender at room temperature according to 
the modified method of Sage and Connette (1969). The homogenate was allowed 
to stand at room temperature for the extraction of proteins and then centrifu-
ged at 10,000 rpm for 15 minutes. The pellet was discarded and the supernatant 
was heated constantly at 60°C for 2 hours in a water bath. The brown, crude 
extract obtained was dialysed against 0.02 M phosphate buffer pH 7.2 and stored 
at -20°C. ' 
3.3.1.2 Purification of lectin by Con A sepharose affinity chromatography 
3.3.1.2.1 CNBr activation of Sepharose *B 
Sepharose ^B was activated by CNBr by a procedure similar to that of 
March et al. (197'f). 10 ml of gel sepharose kb was added to an equal volume 
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of 2 M sodium bicarbonate and mixed by stirring slowly. To this 0.5 ml of a c e -
tonitri le solution of CNBr (2 gm CNBr/ml acetonitrile) was added all at once 
while stirring vigorously for 2 minutes. The slurry thus obtained was washed 
several t imes with 5-10 volumes each of 0.1 M sodium bicarbonate, pH 9.5 and 
water. The slurry was filtered in a sintered glass funnel under vaccum and was 
stored in a bottle containing 0.2 M sodium bicarbonate (pH 9.5). 
3.3.1.2.2 Coupling of activated gel with Concanavalin A 
Coupling was done at 'f^C according to the method of Porath et al. (1967). 
300 mg concanavalin A dissolved in 0.2 M sodium bicarbonate, pH 9.5 was added 
to the CNBr activated gel and stirred for 36 hours. Glycine was added after 
the stipulated time for stopping the reaction. The gel was then washed with 
O.l NA sodium bicarbonate, pH 9.5 several t imes . In this way, 12.2 mg Con A 
was coupled per ml of gel. 
3.3.1.2.3 Preparation of phosphocellulose 
Phosphocellulose was prepared by the method of Peterson and Sober (1961) 
according to which 118 ml of 63.5% NaOH solution was added to 30 gm of cellu-
lose. This mass was kept for 30 minutes on ice bath after which 350 ml of water 
was added slowly to the mixture . 80 ml of ether and W ml POCl^ was mixed 
and slowly added to this mass with continuous stirring at room temperature so 
that the addition is completed in one hour. The phosphocellulose, thus obtained 
was washed with 2 litres of water repeatedly and filtered. It was again washed 
with water and ethanol and dried by evaporating the alcohol and water at reduced 
pressure. 
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3.3.1.2.4 Column chromatography 
Con A sepharose was packed in a column 15 x 1.5 cm. It was washed 
with 1 M NaCl containing 1 mM each of MnCl-.MgCl- and CaCl2. It was then 
equilibrated with 0.02 M phosphate buffered saline (pH 7.2). The crude lectin 
e x t r a c t was passed through the column and was washed with the same 
buffer. The unadsorbed fractions were discarded. The elution of lectin was done 
with 0.1 M a-Methyl-D-glucoside in phosphate buffered saline (PBS). The fractions 
containing hemagglutination activity were pooled, dialysed against the same buffer 
and lyophilized. The residue was reconstituted in small anount of PBS. This 
concentrated solution of 'ectin was aglin dialysed against 0.005 M phosphate buffer 
(pH 5.8) and then applied on a 15 x 1.5 cm column packed with phosphocellulose. 
Before applying the lectin, the column was equilibrated with 0.005 M phosphate 
buffer (pH 5.8). 85% of the hemagglutination activity (F^A-A) was eluted at 
this concentration and pH of the buffer. The remaining 15% hemagglutination 
activity (PH A-B) was eluted by raising the pH of the buffer to 8.2. Both the 
fractions were pooled separately dialysed and lyophilized and reconstituted in 
0.02 M PBS, pH 7.2 
3.3.2 Isolation of Islets of Langerhans from rat Pancreas 
Islets of Langerhans were prepared by the modified collagenase digestion 
method of Brunsted et al . (198^), originally described by Lacy and Kostianovsky 
(1967). Albino meile rats of desired weight were injected with pilocarpine (60 
mg/kg b.w.) intraperitoneally, 2 hours before sacrificing the animal for the removal 
of pancreas. The rats were decapitated and the pancreas were gently removed 
by carefully cutting from the splenic part towards the duodenal part or vice versa. 
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The pancreas was placed in a beaker with ice cold modified Hanks balanced salt 
solution. After cleaning off the extraneous adipose tissue, the tissue was chopped 
into small pieces. The fine pieces were washed several times with HBSS following 
removed of rats. The chopped tissue pieces were allowed to settle down and then 
collagenase 'f mg/ml of packed tissue was added. Incubation was carried out 
in scintillation vials. The vials were incubated with vigorous stirring horizontally 
for 15-20 minutes at 37°C in a metabolic shaker. The incubation was terminated 
by adding 10 ml of HBSS containing 1 per cent BSA to the vials. The islets were 
picked up by means of a pasteur pipette under dissection microscope and transferred 
in Kreb's Ringer Bicarbor.ate Buffer (KRB) containing 3 mg/ml bovine serum albumin, 
12 naturally occurring amino acids, plus 0.01 M nonessential amino acids according 
to Eagle (1959). 
The time of incubation and concentration of collagenase were standardized 
for each batch of collagenase. 
3.3.3 Incubation of Islets of Langerhans with A. bisporus lectin (PHA-B) for 
studies on insulin release 
Groups of five islets from 1, 3, 6 and 12 months old rats isolated by the 
collagenase digestion method mentioned above, were incubated with 1 ml of Kreb's 
Ringer bicarbonate medium (Gey and Gey, 1936) containing 3 mg/ml bovine serum 
albumin, 2mM. Ca"^ "^ , 0.01 M each of naturally occurring amino acids (Eagle, 
1959), 0.01 M each of nonessential amino acids, 2mM glucose and 17.5 yg/ml 
of A. bisporus lectin (PHA-B) (which produces half maximal stimulation of insulin 
release). The medium was constantly gassed with carbogen (95% Oy. 5% CO \ 
and the pH was kept at 7.i^. The incubations were carried out at 37°C in a metabo-
% 
lie shaker. Samples were drawn from the incubating medium for the estimation 
of insulin by radioimmunoassay by the method of Morgan and Lazarow (1963). 
For the protection of insulin against proteolytic enzymes, trasylol was added in 
the incubation medium to give a final concentration of 1,000 KID per ml and 
the samples were stored at -80°C till the insulin assay was performed. 
I15 2+ 3.3.4 Uptake of Ca by Islets in presence of Glucose and Agaricus bisporus 
lectin 
Batches of five islets taken separately in 25 ml conical flasks in which 
was kept KRB containing BSA 3 mg/ml, 12 naturally occurring amino acids accor-
ding to Bagle (1959), nonessential cniino acid 0.01 M, trasylol 1000 KlU and glu-
cose (2 mM). A. bisporus lectin (17.5 yg/ml) and 5 yCi Ca ^ Cf.O mCi/g) in 
the final volume of 1 ml. In the control, lectin was omitted. The reaction was 
carried out for two hours at 37''C in a metabolic shaker. The pH of the medium 
was 7A. The reaction was stopped after 10 min by adding 2 mM lanthanum chlo-
ride. The incubation was followed by 1 hour of washing with nonradioactive basal 
medium, supplemented with 2 mM lanthanum chloride according to the method 
of Hellman et al. (1976). The islets were spun down and washed with LaCl^ 
(2 mM). The islets were then ruptured in 0.1% Triton X-100 followed by freeze 
and thawing (in liquid air). Suitable aliquots were added to 10 ml scintillation 
fluid (0A% 2,5-diphenyl oxazole and 0.01% Ij^ f bis (5-phenyl oxazolyl-2) in toluene 
and 2 methoxy ethanol (1:1 v/v) and radioactive counts were taken in a LKB liquid-
scintillation spectrometer. The results are expressed as cpm/5 islets/hr. 
3.3.5.1 Incorporation of C-4-eucine into Islet Proteins 
Incorporation of C-Leucine into islet protein was carried out in KRB 
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medium containing bovine serum albumin and 12 naturally occurring amino acids 
according to Eagle (1959) except that leucine wcis omitted. The concentration 
of nonessential amino acids in the medium was 0.01 M (basic medium). The incu-
bation was carried out at 37°C in a metabolic shaker (72 oscillations per minute) 
in an atmosphere of 95% 0-> and 5% CO-,. The pH of the medium was maintained 
at 7.k. 
For in \ivo studies, rats from different experimental sets were fasted 
for 2't hours and their islets were isolated. Incorporation of C-Leucine into 
islet proteins and extraction of (pro)insulin was done as described below. 
For in vitro studies, normal male albino rats were fasted overnight. Batches 
of 60-70 islets were isolated and incubated in 1 ml of KRB medium for 30 min 
(preincubation). The medium was then removed and islets were further incubated 
for 2 hours in 1 ml KRB containing 2 mg/ml BSA, 300 mg/dl glucose, 10 iJCi of 
C-Leucine (sp. activity 208 mCi/m mole) and the test material at the desired 
concentration. Cycloheximide control was also run simultaneously where 10 yg/ml 
of cycloheximide was added in the incubation medium. After proper incubation 
at 37°C, islets were rapidly washed with 2 ml of medium containing cold leucine 
(5 mM). Adherent tracer was removed from the islets by incubating in 1 ml basic 
medium containing cold leucine (0.2 mM) for 10 minutes. 
3.3.5.2 Extraction of islet proteins 
Since it is known that no significant release of proinsulin takes place before 
200 min of incubation (Steiner and Oyer, 1967), the above incubation medium 
in which the islets were incubated for a maximum period of 2 hours was discarded. 
The islets were ruptured by freeze and thawing (in liquid air) and subjected to 
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homogenization in cold TCA (10% w/v). It was then centrifuged. The sediment 
was extracted twice with acid ethanol (ethanol:0-phosphoric acid: water; 80:1:19 
v/v) for a total period of 20 hours (Davoren, 1962). The two extracts were pooled 
and the residue was dissolved in IN sodium hydroxide. Suitable aliquots of both 
the fractions were added to scintillation vial containing 10 ml of scintillation 
fluid (0.^ *% PPO and 0.01% POPOP in toluene: 2 methoxy ethanol; 1:1 v/V) and 
counted in LKB liquid scintillation spectrometer. The radioactive counts in the 
extract were taken as an index of C-Leucine incorporation into proinsulin frac-
tion, while incorporation into total islet proteins was determined by adding to 
it the counts in the residue. The results are expressed as cpm/mg islet proteins 
or dpm/mg islet proteins. 
3.3^ Effect of A. bisparus PHA-fi lectin on Cathepsin-B and Acid-phosphatase 
activity in islets of Langerhans in vitro 
60-70 islets were isolated from rat pancreas and incubated with 30 yg/ml 
of lectin exactly in the same fashion as described before. After one hour of 
incubations, the islets were washed severed times with 0.15 M KCl to remove 
the incubating medium and lectin. The islets were then homogenized for assay 
of Cathepsin-B and Acid phosphatase activaty. 
3.3^.1 Preparation of islet homogenates 
Islets, washed with 0.15 M KCl were suspended in 2 ml of cold KCl (0.15 
M) and homogenized using a power driven Potler Elvehjem homogenizer fitted 
with teflon pestle at 6,000 rpm (Remi Udyog, Bombay, India). The homogenate 
was frozen and thawed for 8-10 times so as to rupture membranes of Lysosomes. 
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It was then centrifuged at 750 x g for 20 minutes at k°C. The supernatant was 
directly used for the assay of Cathepsin-B and acid phosphatase activit ies. 
3.3X.2 Enzyme Assay 
3.3^.2.1 Cathepsin-B (E.G. 3.k.22A) 
Cathepsin-B was assayed according to Anson (1938), as modified by Mycel< 
(1970) using hemoglobin as substrate. The reaction mixture (75-80 yg of enzyme 
protein in 0.4M citrate buffer, pH 5.0 and cysteine hydrochloride 0.07 M pH 5.0) 
was preincubated for 5 minutes prior to the addition of hemoglobin (1.55 x 10 M). 
The enzyme reaction was arrested after 60 minutes of incubation at 37°C by 
adding 1 ml of TCA (10% w/v). Trysoine liberated in the acid f i l trate was e s t i -
mated according to Lowry e t al . (1951). Unit of enzyme activity is expressed 
in terms of amount of enzyme liberating one micromole of tyrosine per minute . 
The specific activity is expressed as units of enzyme per mg protein. 
3.3^.2.2 Acid phosphatase (E.G. 3.1.3.2) 
Acid phosphatase activity was assayed according to the method of Bessey 
e t al . (19^6). The assay mixture contained: k mM p-nitrophenyl phosphate; 100 
mM acetate buffer, pH 5.0; 20 mM EDTA; and enzyme protein (75-80 yg). The 
incubation was carried out at 37°G for 60 minutes. The reaction was stopped 
by adding 2 ml of 0.1 N sodium hydroxide, p-nitrophenol released was read at 
UIO nm. 
One unit of enzyme activity has been expressed in te rms of amount of 
enzyme which liberate one n-mole of p-nitrophenol per minute . The specific 
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activity has been expressed in terms of units of enzyme/mg protein. 
3.3^.2.3 Protein kinase (E.G. 2.7.1.37) 
Protein kinase activity was determined in the islet preparations in the 
presence of added hist one (type II a, Sigma Chemical Co.) according to Lipson 
et al. (1981). Optimal activity was at pH 7.5 in a lO.mM Tris-HCi, 5 mM MgCJ2 
and 10% sucrose reaction buffer. The assay conditions were as follows. 25 yl 
of ice cold islet homogenate (3-5 yg protein) in appropriately concentrated reac-
tion buffer were preincubated for 1 min at 37°C in a plastic tube. After the 
preincubation 10 yl of water were added in the incubation tube (1.0 yM final 
concentration which gave maximal stimulation. Thirty seconds later, 10 yl his-
tone (100 yg) in water were added to the reaction mixture. The reaction was 
started by adding 25 yl solution of [y-^^P] ATP (5 x 10"^ M; 2-6 x 10^ dpm) in 
water and was terminated after 30 seconds (under which conditions linearity of 
the reaction rate was maintained) by the simultaneous addition of 0.5 ml of 10% 
TCA and 0.2 ml of 6.25 mg/ml BSA to the reaction volume of 70 yl. The pre-
cipated protein was cooled to U°C and centrifuged, the supernatant was removed 
and the pellet was dissolved in 0.5 ml of 0.125 N NaOH. This procedure of preci-
pitation with TCA and solution in NaOH was repeated four times, and the final 
precipitate was dissolved in 1.0 ml of 0,125 N NaOH. 0.5 ml of this was assayed 
for radioactivity. Reaction blanks for each sets of experiments were determined 
in the absence of islet homogenate. The activity of protein kinase was calculated 
32 from the specific activity of the [y- P] ATP in the incubation mixture and the 
32 
amount of P incorporated into the washed TCA precipitates after substraction 
of the reaction blanks. Unit of enzyme activity is expressed as picomoles of 
POj^  incorporated into TCA precipitate/mg islet protein/min. 
3.3.7 Estimation of protein 
Protein was estimated according to the method of Lowry et al. (1951) 
using bovine serum albumin as standard. 
3.3.8 Studies on conversion of proinsulin to insulin by A. bisporus lectin in vitro 
and effect of age thereon 
3.3.8.1 Incubation procedures 
Approximately 6-70 islets from one and 12 months old rats were taken 
in each tube and incubated in final volume of 1 ml KRB containing 2% BSA, trasy-
lol (1000 KlU/ml) naturcilly occurring amino acids (except leucine) according to 
Eagle (1959) and 50 yCi of C-Leucine (sp. activity 208 mCi/m' mole). Glucose 
was present in the incubation media at a concentration of 300 mg/dl. Lectin 
(30 iJg/ml) was added in the experimental tubes. Incubations were carried out 
under a constant atmosphere of 95% O^ and 5% CO2 (v/v) for 2 hours, in a meta-
bolic shaker. 
3.3.8.2 Extraction of islet proteins 
Method for extraction of (pro)insulin and other proteins was essentially 
similar as described above. The (pro) insulin fraction was evaporated to dryness 
in vacuo and residue was dissolved in 1 ml of 0.02 M borate buffer pH 7.6. It 
was then applied to a column of sephadex G-50 (1.5 x 55 cms) preequilibrated 
with 0.02 M borate buffer pH 7.6. 
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3.3.8.3 Characterization of biosynthetic products 
The radioactivity was measured in 0.1 ml sample of each fraction in 13 
ml scintillation fluid: 0A% PPO and 0.01% POPOP in toluene: 2-methoxy ethanol 
(1:1 v/v) and counted in LKB liquid scintillation spectrometer. The immunoreactive 
insulin and proinsulin content of the samples were measured after appropriate 
dilution in phosphate buffer (pH 7A) containing 0.2% BSA. Fractions were also 
monitored at 280 nm. 
3.3.9 Lectin Binding Studies 
3.3.9.1 Effect of age on binding of PHA-B lectin to isolated islets of Langerhans 
in -vitro 
The binding studies were carried out according to the method of Ewart 
et ai. (1975). 
125 A. bisporus PHA-B lectin was iodinated with I by the method of Hunter 
(1967) carrying out a ten second exposure to chioramine T. The specific activity 
of the iodinated product was approximately 0.1 yCi/yg. Following iodination, 
the lectin was tested for its erythrocyte agglutinating activity. For binding studies, 
groups of 15 islets of comparable size from 1, 3, 6 and 12 months old rats were 
incubated in the above described buffer along with 30 lig/ml iodinated lectin. 
The incubation was carried out at 37°C in a metabolic shaker for 75 minutes 
and the islets were then exposed to one hundred-fold-volume excess of lectin 
free medium for two minutes. The islets were then filtered and washed on milli-
pore filters. The bound radioactivity was assayed by counting the filters directly 
on LKB gamma spectrometer. In all the experiments non-specific binding of 
63 
the labelled lectin to the filters was detfirmined by filtration of incubation media 
without added islets. Results are expressed as dpm/15 islets or ng of lectin 
bound/15 islets. 
125 3.3.9.2 Effect of various glucose concentration on binding of I4^ctin to 
islets of Langerhans in vitro 
Fifteen islets of comparable size were isolated and preincubated in flasks 
containing the medium as described above along with 50, 100, 200, 300 and ^50 
mg/dl glucose. The medium was then removed and further incubation of islets 
was carried out at 37°C for 75 minutes in a fresh medium containing 30 yl/ml 
of iodinated lectin. The islets were then exposed to one hundred fold volume 
excess of lectin free medium for two minutes. The islets were then filtered and 
washed on millipore filters as described above. Results are expressed as above. 
3.3.10 Incubation of CCK-4 Tetrapeptides with islets of Langerhans for studies 
on insulin and glucagon release 
Groups of 5 islets were incubated with 1 ml KRB (containing 3 mg/ml 
BSA, 12 naturally occurring amino acid according to Eagle (1959), 0.01 M non-
essential amino acids, 1000 KlU/ml trasylol, and 2 mM glucose)^ and the CCK-
-10 -3 
k tetrapeptides in the concentration range of 10 to 10 M. As in other insulin 
secretion studies, the incubations were carried out at 37°C in a metabolic shaker 
at pH 1 .^ for 3 hours. Samples were drawn from the media at an interval of 
1 hour for the estimation of insulin and glucagon by radioimmunoassay. Results 
are expressed as yU/5 islets/hr and pg/5 islets/hr for insulin and glucagon, 
respectively. 
eif 
3.3.11 Incubation of (-) ^icatechin with Islets of Langerhans for studies on 
insulin release 
Group of 15 islets were incubated with 1 ml KRB containing 3 mg/ml 
BSA, 12 naturdly occurring amino acid according to Eagle (1959) 0.01 M non-
essential amino acids, 1000 KlU/ml trasylol and (-) Epicatechin dissolved in abso-
lute ethanol was added to a final concentration of 200, 'tOO, 600, 800 and 1000 
ViM. The glucose concentration of the medium was 2 mM and 20 mM. A separate 
control was run with each experiment in which (-) Epicatechin was omitted. 
Similarly to other insulin secretion studies, the incubations were carried out at 
37°C in a metabolic shaker at pH 7A for 3 hours. Samples were drawn from 
the media at an interval of 1 hour for the estimation of insulin by radioimmuno-
assay. Results are expressed as ;MU/5 islets/hr. 
3.3.12 Effect of (-) ^icatechin on the activities of glucose-6-phosphatase and 
phosphofructokinase in isolated islets of Langerhans in ^ntro 
60-70 islets were isolated and incubated with 1 mM (-) Epicatechin for 
2 hours as described earlier. The islets were then washed with 0.15 M KCl to 
remove adhering (-) Epicatechin and incubating medium. The islets were then 
homogenized and processed for enzyme assay. 
3.3.12.1 Preparation of islet homogenates 
Homogenate of the islets was prepared as described earlier and centrifuged 
at 750 X g for 20 minutes at '^"C. The supernatant was directly used for the 
assay of glucose-6-phosphatase and phosphofructokinase activities. 
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3.3.12.2 Enzyme Assay 
3.3.12.2.1 Gluoose-6-phosphatase (E.C. 3.1.3.9) 
Glucose-6-phosphatase (D-glucose-6-phosphate phosphohydrolase, E.G. 3.1.3.9) 
was estimated according to Harper (1963). The 0.3 ml reaction mixture contained 
0.1 ml of 0.1 M citrate buffer pH '6.5, 0.1 ml of 0.08 M prewarmed G-6-P and 
0.1 ml of enzyme protein. The mixture was incubated for 15 minutes at 37°C 
and the reaction was stopped by adding 2 ml of 10% TCA. The Pi liberated was 
estimated according to Fiske and Subbarow (1925). Unit of enzyme is expressed 
as ymol of Pi liberated/mg protein/hr. 
3.3.1222 Phosphofructokinase (E.C. 2.7.1.11) 
Phosphofructol<inase was assayed according to the method of Massey cjid 
William (1973). The enzyme activity was determined by a coupled spectrophoto-
metric assay. The decrease in the absorbance at 340 nM was monitored. The 
assay reaction mixture contained 50 mM Tris HCl, pH 8.0; 50 mM 2-mercaptoe-
thanol; 5 mM MgC^; 2 mM ATP; a-Giycerol phosphate dehydrogenase and triose 
phosphate isomerase (50 yg/ml), aldolase (0.1 mg/ml), enzyme source (about 2 
Ug/ml protein) and t^ mM fructose 6 phosphate, which was added last to initiate 
the reaction. Approximately 40 mM ammonium sulphate was introduced into 
the assay mixture with the auxiliary enzymes. Unit of enzyne is expressed as 
ymol of fructose 1,6 diphosphate formed per mg DNA per hour. 
3.3.123 Assay of DNA 
DNA content of islets was assayed by the method of Hinegardner (1971) 
using calf thymus DNA as standard. Aiiquots of the islets homogenate was taken 
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in a tube and dried in an oven at 50°C. 100 yl of 3,5 Diamino benzoic acid {0.^ 
gm/ml) was added and the tubes were placed in a 60°C water bath for ^3 minutes. 
1.5 ml of 1.0 N HCI was added to the tubes before taking the readings in a spe-
ctrofluorometer. The reading was taken at ^^ 20 nm and 520 nm excitation and 
emission wave length respectively. An appropriate blank was prepared in which 
no DNA source was added. 
3.3.13 Studies on the hypoglycemic properties of Pterocarpus mar^jpium Roxb. 
3.3.13.1 Extraction of the Material 
Wood of Pterocarpus marsupium was chopped into small pieces and ex t r a -
cted in absolute alcohol for one week. The alcoholic extract was dried and r eex -
tracted by ethyl ace ta t e . This ethyl ace ta te soluble fraction of the alcoholic 
extract (XE) was dried and used for subsequent studies. 
3.3.13.2 Doses and administration 
Charles Foster albino rats weighing 200-250 g at the beginning of the study 
was used. The animals were divided into three groups, namely, normal controls, 
alloxan diabetic control and compound t reated diabetic group. Ten rats were 
taken in each group. 
Group A: Normal controls: These animals were fed with normal saline 
instead of the plant ext rac t . 
Group B : Alloxan diabetic control : Animals were injected with alloxan 
monohydrate (50 mg/kg b.w. iv). Hyperglycemia was confirmed after 2^ hours 
of injection with the help of -Erne's Diastix strips. 
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Group C : Extract treated alloxan group : Animals injected with alloxan 
monohydrate intravenously. After development of hyperglycemia, the rats were 
fed orally with the extract (250 mg/kg b.w.) suspended in water twice daily for 
5 days. 
On the 6th day, the overnight fa^ t^ed rats from all the three groups were 
bled and their blood glucose was estimated by the glucose oxidase-petoxidase 
method of Huggot and Nixon (1957). Results are expressed as mg/di (mg %)• 
3.3.13.3 Glucose tolerance test (GTT) 
Glucose tolerance test was carried out according to Duffy et al. (1973) 
employing 1.75 g glucose per kg body weight. The blood was withdrawn at zero, 
one, two and three hours after glucose administration. Glucose was estimated 
by the glucose oxidase peroxidase method of Huggot and Nixon (1957). 
3.3.13.* Assay of serum insulin ley^l 
Serum of all the three groups of rats was separated and insulin assay 
was carried out by the radioimmunocissay method of Morgan and Lazarow (1963). 
Results are expressed as yU/ml. 
14 3.3.13.5 C-Leucine incoq>oration into (pro)in$ulin 
Animals of the above three groups were sacrificed and their islets were 
isolated, incubated and processed as described earlier for studying the capacity 
of the islets, from all the three age groups, to synthesize (pro)insulin as assessed 
K l '^ 
oy C-Leucine incorporation. The results are expressed as cpm/mg islet protein. 
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3.3.14 Radioimmunoassay of Insulin 
Radioimmunoassay was carried out, using RIA kit (BARC) according to 
the method of Morgan and Lazarow (1963) with slight modification as described 
below: 
Method : 0.3 ml EDTA-phosphate buffer (0.01 M EDTA, O.Of M phosphate, pH 
7.1*), containing 0.5% BSA (w/v) was mixed with 0.1 ml of standard insulin or 
unl<nown samples and 0.1 ml of antibody (antiinsulin guinea pig serum diluted 
125 1:1,000,00 times) and kept overnight at '^°C. 0.1 ml of MnsuJin (about 1 x 
10 cpm) was then added to the sample mixture and was again kept for 5 minutes 
at ii°C. After that 0.1 ml of second antibody (anti guinea pig y-globulin raised 
in rabbit) was added. Complete antigen antibody complex precipitation was done 
by the addition of 1 ml of 12% polyethylene glycol 6000. 
The tubes were then centrifuged at ii,000 rpm for 20 minutes and the 
radioactive counts in the precipi tate was counted in LKB Autogamma spectrometer . 
125 Per cent binding of I-insulin was calculated. Two total count tubes (only 
125 
I-insulin), two non-specific binding tubes (only antigen without antibody) and 
the experimental tubes were run. Dose response curve was drawn by plotting 
insulin concentration against per cent binding (Figure 14). The results are expre-
ssed aspU/ml or islets. 
3.3.13 Radioimmunoassay of Glucc^on 
Radioimmunoassay of glucagon was carried out by Glucogen RIA (Serono-
diagnostic, Switzerland) according to the method of Hazzard et al. (1968) with 
minor modification as described below: 
o 
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Method : 0.2 ml of the sample or standard was mixed with 0.1 ml of glucagon 
antiserum and incubated for 3 hours at 'f^C in a refrigerator. This was followed 
125 
by addition of 0.1 ml of 1-Glucagon on a vortex mixer. The tubes were incu-
bated for 20-2't hours at '^ "C in a refrigerator. 0.1 ml of carrier serum was added 
to all the tubes after the incubation. 1.0 ml of 20% polyethylene glycol 6000 
was added to precipitate the antigen-antibody complex. The tubes were centrifu-
ged at ^000 rpm and the radioactivity counts in the precipitate were recorded 
125 by LKB Autogamma spectrometer. Percent binding of I-Glucagon was calcu-
125 
lated. For control, two total counts tubes (only 1-Glucagon) and two non-spe-
cific binding tubes (only antigen) were run together with the experimental tubes. 
Dose response curve was drawn by plotting glucagon concentration against 
per cent binding (Fig. 15). The results are expressed as pg/5 islets/hr. 
3.3.16 Statistical Analysis of Results 
Levels of statistical significance for the differences between control and 
experimental values were determined by employing students 't ' test. 
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4.0 RESULTS 
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4.1 Effect of age on A. bisporus PHA-B stimulated insulin release from islets 
of Langerhans in vttro 
The pat tern of insulin release from the islets of various age groups of 
rats in the presence and absence of PHA-B lectin, is shown in Figure 16. With 
the suboptimal glucose concentration in the medium PHA-B stimulated the release 
of insulin quite significantly. This stimulation of insulin release by the lectin 
decreased with the advancement of animals' age. Thus, while the insulin release 
in the presence of the lectin in the case of islets of one month old rat was 
88 ± 8.1 yU/5 islets/hr (2.3 fold increase as oompared t o control), the release 
of insulin in the case of 12 months old rat in response to A. bisporus (PHA-B) 
lectin was only liS ± 5.2 yU/5 islets/hr, the control value being 33 ± ^.5 yU/5 
islets/hr (1.4 fold increase). From Figure 16, it would appear that PHA-B lectin 
induces 1.7 fold increase in insulin release in islets from one month old rat as 
compared to that of 12 months old ra t . 
45 2+ 
4.2 Effect of age on Ca iptake in response to A. bisporus PHA-B lectin 
Figute 17 depicts the result of the effect of the lectin on '^^Ca^+ ^ |^  
by islets isolated from 1, 3, 6 and 12 months old ra ts . The medium contained 
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^5 2+ 
only stimulatory concentrations of glucose (2 mM). Ca uptake by islets in 
response to 2 mM glucose did not change with age. Thus, at substimulatory con-
centrations of glucose in the medium, the insulin secretion (Figure 16) and Ca 
uptake by the islets (Figure 17) were cilmost the same irrespective of animals' 
age. However, when 17,5 ug/ml of PH A-6 lectin was added in the medium, it 
'f5 2+ 
significantly stimulated the uptake of Ca by the islets isolated from younger 
animcils as compared to the incorporation into islets isolated from older ones. 
if5 2+ The increase in Ca uptake in the presence of lectin was 52.5 fold in the 
case of islets of one month old rats as compared to the control when incubated 
for one hour. Whereas under similar conditions the islets from 12 months old 
if 5 2+ 
rats showed only 18 fold uptake of Ca as compared to the control. Thus, 
k5 2+ the Ca uptake in response to PHA-B lectin in islets of one month old rats 
registered a 5 fold increase as compared to that in 12 months old rats. 
14 
*.3 Effect of age on proinsuiin/insulin content and C-Leucine incorporation 
into (pro)insulin in the islets of Langerhans and the effect of RIA-B lectin 
thereon. 
The proinsulin/insulin content of the islets of Langerhans in different age 
groups of rat was determined. The result is shown in Figure 18. It can be seen 
frcxn the figure that the content of proinsulin/insulin increases with the increasing 
age of the animal. The content of proinsulin/insulin is about two times higher 
in 12 months old rats compared to one month old rat. However, when the islets 
were incubated with the PHA-B lectin (30 yg/ml), the content of proinsulin/insulin 
was raised to about 't times in the case of one month old rats whereas there is 
only 1.2 fold increase in the case of 12 months old rats. The results of the effect 
of lectin on the incorporation of C-leucine into (pro)insulin in islets of different 
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n 
age groups of rats is given in Figure 19. It is evident from the results that the 
PHA-B lectin significantly stimulated the incorporation of the radioactivity into 
the islets. Compared to control (without lectin), there was about 3 fold stimula-
tion in the incorporation of C-leucine by the lectin in the case of one month 
old rats. On the other hand, there was only \.5 fold increase in the incorporation 
I'f 
of the radioactivity in the case of 12 months old rats. Thus, the ratio of C-
leucine incorporation into the islets of 12 months old rats and that of one month 
old rats was \'A. This ratio was significcintly increased when the islets were exposed 
to the lectin and in this case the ratio of the incorporation of C-leucine between 
the islets of 12 months old rats and one month old rats was 1:7.5. The biosynthesis 
in the presence of the lectin was completely blocked by cycloheximide. 
^A Studies on the KgpricMS bisporvs (RiA-B) lectin stimulated conversion of 
proinsulin to insulin 
(i) Identification of proinsulin and insulin peal<s by gel filtration. 
The elution of profile of standard bovine insulin is shown in Figure 20. 
Most of the insulin was eluted between 50-70 ml of effluent. A smaller peak bet-
ween 30-^ ^5 ml of effluent can be attributed to proinsulin. 
When the islets were incubated in KRB containing Cleucine, approxi-
mately 75% of the radioactivity incorporated in the islets was detected in proin-
sulin and insulin peaks as characterized by Sephadex G-50 filtration of the islet 
extract (Figure 21). Peak P, on incubation with trypsin was converted to insulin 
as characterized by radioimmunoassay and, therefore, characterized as proinsulin. 
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Fig. 21. Gel filtration of acid ethanol soluble proteins on sephadex G-50. 
Islets were incubated for 2 hrs, extracted with acid ethanol and 
subjected to gel filtration as described in the text. 
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On the other hand, no tryptic conversion was observed when pooled fractions 
of second peak were treated in the same way. Figure 22 shows the elution pat t -
ern of immunoreactive insulin when the islet extract was passed through sephadex 
G-50 column. Peak 'I' contained maximum immunoreactive insulin, some of the 
immunoreactive matericd was also present in the proinsulin peak. However, no 
immunoreactive material was found in the void volume. 
4.3 Agaricus bisporus (PHA-B) lectin stimulated conversion of proinsulin to insulin 
and effect of age thereon 
It is quite evident from Figure 23 that lectin PHA-B stimulates the conver-
sion of proinsulin to insulin quite significantly. In the islets of oi>e month old 
rats, 15.25% of the immunoreactive material was characterized as proinsulin. 
However, when the islets were incubated in the medium containing PHA-B lectin, 
only 9.5% of the immuno reactivity was characterized as proinsulin (Figure 2^). 
The corresponding insulin peaks were 8^.7% and 90.5% for control and experimental 
islets respectively (Figure 25) registering a 37% decrease in the proinsulin peaks 
in the case of lectin treated islets as ccmpared to the control (Figure 26). Fur-
thermore, it is evident from the results that age has a pronounced effect on the 
lectin mediated transformation of proinsulin. It can be seen that the rate of 
conversion of proinsulin to insulin in the presence of lectin was markedly dimi-
nished in the case of islets from 12 months old rats as compared to the islets 
from younger rats (one month). Thus there was l'f% more conversion of proinsulin 
to insulin in the case of islets from one month old rat than in the islets of 12 
months old rats when exposed to PHA-B lectin. 
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Fig. 22. Elution profile of immunoreactive insulin of the 
extract of incubated islets after passing through 
sephadex G-50 column. Vo, P and I represent 
the elution volume of blue dextran, proinsulin and 
insulin, respectively. 
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lectin. (30 ug/ml). 
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125 4 ^ Effect of age on the binding of I-lectin to islets of Langerhans in vitro 
125 Figure 27 depicts the binding pattern of I-lectin to the islets from 
different age groups of rats. It is evident from the curve that the binding of 
125 
I-lectin decreased with the increase of the animals' age. Nearly 22.^ *1 ± 2.^ *1 
ng of lectin was bound to the islets of one month old rats, whereas binding of 
lectin to islets of 12 months old rat was only 7.51 ± 1.87 ng (p< .001 as com -
pared to one month old rat). Hence, there was nearly 3 fold decrease in the 
binding of lenctin in the case of islets from 12 months old rat as compared to 
that of one month old rat. However, only 17.12 ± 2.21 ng of lectin was bound 
to islets from three months old rats (p<0.01 as compcired to one month old rat). 
125 
*.7 Effect of glucose on the binding of I labelled A. bisporvs (PHA-B) lectin 
to islets of Langerhans in vitro 
There was no significant change in the binding pattern of labelled lectin 
to islets of Langerhans when the islets were incubated with increasing concentra-
tion of glucose in the medium and nearly the same amount of lectin was bound 
to the islets in the absence and presence of varying amount of glucose (Table 
III). 
4.8 Effect of PHA-B lectin on cathepsin B and acid phosphatase activity in 
islets of Langerhans in vitro 
The effect of the lectin on the activities of cathepsin-B and Acid phospha-
tase is shown in Table IV. 
There was a significant stimulation of Cathepsin-B activity in the islets 
when incubated with PHA-B lectin. The stimulation of the enzyme activity by 
the lectin was found to be about ten fold when compared to the control islets 
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125 Fig. 27. Effect of age on the binding of I-lectin to islets of 
Langerhans in yntro. The islets were incubated wi th 30 yg /m l 
of iodinated lect in and incubated for 75 minutes. The islets 
were then washed and counted on LKB autogamma spectrometer. 
The bars represent the mean (+S.D.) of 6 experiments. 
*p<0.001 as compared to one month old rats. 
* p<0.01 as compared to one month old rats. 
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125 TABLE III - Effect of glucose on binding of J-lectin to the islets of 
Langerhans 
Glucose cone. dpm X 10" /15 islets ng of lectin/15 islets 
bound 
«f7.0t ± 8.68 21.72 ± t^.Ql 
50mg/dl f l . l7 ± 6.97 19.01 ± 3.22 
100 mg/dl 37.92 ± 6.36 17.51 ± 2.9^ 
200mg/dl 'fO.37 ± 8.0 18.6it ± 3.71 
300 mg/dl ^^ 2.10 ± 6.6 19.4^ ± 3.08 
^^ 50 mg/dl 36.77 ± 6.9 16.98 ± 3.19 
Results are expressed as mean ± S.D. for 6 different observations, 
p =NS. 
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TABLE IV - Effect of PHA-B lectin on cathepsin-6 and acid phosphatase 
activity in islets of Langerhans in vitxo 
Enzyme Control Experimental 
(2 mM glucose) (2 mM glucose + lectin) 
Cathepsin-6** 0.28 ± 0.05 1.5 ± 0.2* 
Acid phosphatase 7.6 ±1.3 8.15± 1.35 
Results are expressed as mean + S.D. for 6 different observations 
*p<0.00i;"p =NS 
* *vmoles of tyrosine liberated/mg protein/minute 
+ + nmoles of p-nitrophenol formed/mg protein/minute 
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(p<0.001). On the other hand, there was no significant stimulation of acid phos-
phatase by the lectin where the activity of acid phosphatase was 7.6 ± 1.3 and 
8.15 ± 1.35 units/mg protein for control and experimental islets respectively (P =NS). 
*.9 Effect of BIA-B lectin concentration on Cathepsin-B acti^ty in islets of 
Langerhans in vitro 
Figure 28 shows the effect of A. bisporus (PHA-B) lectin on 
Cathepsin-B activity in isolated islets of Langerhans. The results show that there 
was a constant increase in the activity of this enzyme with the increasing concen-
tration of the lectin upto 30jjg/ml after which there was a slight decrease in 
the enzyme activity. There was more than four fold stimulation of this enzyme 
when the concentration of the lectin in the incubation media was increased from 
5 yg/ml to 30 yg/ml. Hence 1.3 + 0.07 units/mg protein was observed in case 
of islets incubated with 30 pg/ml of lectin whereas only 0.3 ± 0.03 units/mg pro-
tein was seen in case of islets exposed to 5 pg/ml of lectin (p<0.001). However, 
a further increase in the concentration of lectin in the incubation medium resul-
ted in decrease of cathepsin-B activity. Thus from 1.3 ± 0.07 units/mg protein 
at lectin concentration of 30 yg/ml, the activity of the enzyme with 45 yg/ml 
of lectin decreased to 1.01 ± 0.06 units/mg protein and a further decrease was 
observed at 60 yg/ml of lectin concentration where the enzyme activity was only 
0.96 + 0.07 units/mg protein. 
*.10 Effect of A. tisporus (PHA-B) lectin on protein kinase actiwty of islets 
of Langerhans in vitro 
Islets of Langerhans isolated from one and twelve months of rats were 
incubated with or without A. bisporus (PHA-B) lectin. Protein kinase activity 
was assayed in islet homogenate. The result is shown in Table V. It is evident 
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Fig. 28. Effect of Agaricus bisporus (PHA-B) lectin on cathepsin-B activity 
in islets of Langerhans in vitro. 
Enzyme activity is expressed as y moles of Tyrosine liberated/mg 
protein/minute. 
The bars represent the mean (+S.D.) of 6 experiments. 
*p< 0.001 as compared to the enzyme activity at 5 \Jg/m\ of lectin 
concentration. 
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TABLE V - Effect of PHA-B lectin in vitto on protein kinase activity in 
islets of Langerhans and effect of age thereon 
Age Control Experimental 
One month 123 ± 6.2 128 ± 7.5* 
Twelvemonths 133 ± 9.2 B^t ± 8.7* 
Results are expressed as mean + S.D. of 6 different observations. 
* p =NS 32 
+ p moles of PO. incorporated/mg protein/minute. 
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that there was no significant change in the enzyme activity in the experimental 
islets (incubated with PHA-B lectin). Protein kinase activity of control and expe-
rimental islets as shown in the table were 123 ± 6.2 and 128 ± 7.5 units/mg protein 
respectively (p = NS) in the case of one month old islets. Moreover, age had 
no pronounced effect on the activity of this enzyme which exhibited 133 ± 9.2 
units/mg protein in the case of 12 months old islets incubated with PH A-6 lectin 
(p =NS). 
4.11 Effect of (-) ^icatechin on insulin release from islets of Langerhans in 
^ntro 
Figure 29 shows the pattern'of insulin release by (-) Epicatechin. It is 
evident from the figure that (-) Epicatechin stimulated insulin secretion from 
isolated islets of Langerhans in a dose dependent fashion, both in the presence 
of 2 and 20 mM glucose in the medium. One millimolar epicatechin produced 
optimal response from islets exposed to low or high glucose medium. At this 
concentration of epicatechin, insulin release was raised from 39 ± 5.1 to 117.3 
± 8.5 viU/5 islets/hr (p<0.01) in the presence of 2 mM glucose and from 12^ ^ ± 
8.2 to 193.7 ± 9.0 vtU/5 islets/hr in the presence of 20 mM glucose (p<0.001). 
'^ .12 Effect of (-) Epicatechin on C-leucine incoq>oration into (pro)insulin in 
islets of Langerhans in vitro 
Islets were incubated with or without (-) Epicatechin along with C4eu-
cine. There was a significant increase in the incorporation of C-leucine into 
(pro)insulin when islets were incubated with various concentrations of (-) Epica-
techin (Figure 30). At 200 \iM of (-) Epicatechin, there was 50% increase in the 
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Fig. 29. Effect of (-) Epicatechin on in vitro insulin release f rom islets 
of Langerhans in the presence of 2 m M (hollow circles) and 20 
miVi glucose (bold circles). The bars represent the mean (±S.D.) 
of 6 experiments. 
*p<0.001 as compared to control (without epicatechin). 
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incorporation of the radioactivity. The incorporation of C4eucine increcised 
with the increasing concentration of (-) Epicatechin. Maximum stimulation in 
the biosynthesis of (pro)insulin was observed at 1 mM concentration of (-) Epica-
techin where 70% increase in the insulin biosynthesis was registered. Nearly 
a complete block in the biosynthesis of (pro)insulin wcis observed in the presence 
of cycloheximide (data not shown). 
4.13 Effect of (-) Epicatechin on Glucose-6-phosphatase and phosphofructo-
kinase activity in islets of Langerhans in vitro 
Table VI shows the glucose 6 phosphatase activity in isolated islets of 
Langerhans when the islets were incubated with or without 1 mM (-) Epicatechin 
on the medium. It is evident from the table that the G-6-Pase activity was m a r -
kedly diminished by the incubation of islets with (-) Epicatechin. The activity 
of this enzyme was 0.29 ± 0.022 units/mg protein, in the case of experimental 
islets, and 0.38 + 0.026 units/mg protein in the case of control islets [without 
(-) Epicatechin] (p<0.001). 
(-) Epicatechin, on the other hand, increased the activity of the phospho-
fructokinase in the whole homogenate of the islets. The data presented in Table 
VII shows that the phosphofructokinase activity in the islet homogenate was 
250 ± 10 units/mg DNA when the islets were incubated in the medium without 
epicatechin (control). However, when the islets were incubated with epicatechin 
in the medium the activity of phosphofructokinase rose to 288 + 1 5 units/mg DNA 
(p<0.01). 
'^.1'^ Studies on the hypoglycemic properties of wood extract of Pterocarpus 
marsupium Roxb. 
Effect of feeding of ethyl ace ta te soluble fraction (XE) of alcoholic extract 
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TABLE VI - Effect of (-)Epicatechin on glucose 6 phosphatase^ activity 
in islets of Langerhans in vitio 
Control 0.38 ± 0.026 
[2 m M glucose] 
Experimental 0.29 ± 0.022* 
[(2 mM glucose + 
1 mM (-)Epicatechin] 
Vmol of Pi released/mg protein/hr. 
Results are expressed as mean ± S.D. of 6 different observations. 
*p<0.001. 
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TABLE VII - Effect of (-)Epicatechin on phosphofructokinase activity 
in islets of Langerhans in vitxo 
Control 250 ± 10 
[2 m M glucose] 
Experimental 288 ± 15* 
[(2 mM glucose + 
1 mM (-)Epicatechin)] 
vmoles of product formed/mg DNA/hr 
Results are expressed as mean ± S.D. of 6 different observations. 
*p<0.01. 
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of Pterocarpus marsupium wood on fasting blood sugar level of rat is shown in 
Figure 31. The feeding of wood extract resulted in a significant lowering of 
the fasting blood sugar level in the alloxan induced diabetic rats as compared 
to the control (alloxan diabetic animals without drug). Thus, injection of alloxan 
to rats caused about 5 fold increase in the blood sugar level (p<0.001 as compared 
to normal control) and the feeding of the extract to the alloxan diabetic animals 
lowered the blood sugar by 70% as compared to the alloxan control rats (p<0.001). 
Glucose tolerance test on the alloxan dicibetic rats which were fed with 
XE showed a marked improvement their glucose lowering capacity (Figure 32). 
One hour after feeding of glucose the blood sujar rose to 89.39 ± 13.8 and 1^71A2 
± 16.0 mg% in the case of normal and alloxan diabetic rats respectively. However, 
when the wood extract was fed to eilloxan diabetic rats, there was about 2 folds 
decrease in the blood sugar level after one hour of glucose load [p<0.001 as com-
pared to control (alloxan diabetic without feeding the drug)]. 
After 3 hours of glucose load the blood glucose came down to the basal 
level, i.e. the fasting sugar level of normal rats, whereas alloxan diabetic rats 
without epicatechin treatment failed to lower effectively the glucose load and 
even after 3 hours of glucose feeding the blood glucose level was about 1.2 fold 
higher than the zero hour level (p<0.001 as compared to zero hour level). On 
the other hand, a significant improvement in the tolerance was observed in the 
case of XE treated rats. In this case, after 3 hours of glucose load the glucose 
level showed 7'f.4% decrease as compared to untreated alloxan diabetic rats. 
Their blood glucose level after 3 hours was only slightly higher than the zero 
hour level (9.8 %; p = NS). 
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Fig. 31. Effect of Pterocarpus marsupium extract (XE) on blood 
glucose; level in alloxan diabetic rats. Tlie bars repre-
sent the mean (+S.D.) of t^ experiments. 
*p<0.001 as compared to normal control. 
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Fig. 32. Ellect ol Pterocarpus marsupium extract (XE) on glucose 
tolerance test in allojwn diabetic rats. The bars represent 
mean (±S.D.) of 14 experiments. 
*p<0.001 as compared to alloxan diabetic control. 
**p<0.001 as compared to zero hour level. 
+p = NS as compared to zero hour level. 
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Serum of the three groups of these rats, namely, normal control, allo-
xan diabetic control and XE treated were assayed for the insulin levels by 
RIA. It is evident from Figure 33 that there was a significant increase in 
the insulin level of XE treated rats. About itOA% increase in the insulin level 
was seen in experimental rats (XE treated, p<0.01 as compared to alloxan 
diabetic rats). Five days treatment of the rats by XE fraction of the wood 
extract of P. mauapium raised the insulin level of the serum from 9.k3 + 2.3 
to 15.75 ± 3.8 yU/ml serum. 
Islets of these three groups of rats were isolated and the incorporation 
of C-Leucine into (pro)insulin fraction v/as studied. The results are presented 
in Figure 3^ *. The treatment of diabetic rats with XE resulted in an increased 
capacity of their islets to synthesize (pro)insulin. Islets from the treated rats 
showed a marked increase in the incorporation of the radioactivity as compared 
to the islets from alloxan diabetic rats. 65% decrease in the incorporation 
of radioactivity was observed in the case of islets from alloxan diabetic animals 
(p<0.001; as compared to normal control). However, when the islets isolated 
from XE treated rats were incubated with C4-eucine 104% increase in the 
incorporation of radioactivity into (pro)insulin was observed (p<0.001; as compared 
to alloxan diabetic islets). 
4.15 Effect of synthetic analogues of C-terminal Tetrapeptide amide of 
Cholecystoidnin (CCK-'^ ) on Insulin release from Islets of Langerhans 
in vitto 
The peptides were tested for their insulin releasing activity on the 
isolated islets of Langerhans of rat pancreas. The following six analogues 
of CCK-41, along with the parent peptide CCK~^ were incubated with islets 
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Fig. 33. Effect of Pterocarpus marsupium extract (XE) on serum 
iDsulin level in alloxan diabetic rats. The bars represent 
mean (±S.D.) of 'f experiments. 
*p<0.01 as compared to alloxan diabet ic rats. 
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at concentrations ranging from 10" M t o l O ' M i n the incubation medium: 
CCK -^  Trp - Met - Asp - Phe - NH 2 
I Phe - Met - Asp - Phe - NH2 
II Tyr - Met - Asp - Phe - NH2 
III Trp - Leu - Asp - Phe - NH 2 
IV Trp - Ser - Asp - Me Phe 
V Trp - Met - Asp - Me Phe 
Pro - Met - Asp - Phe - NHCH^ VI 
_9 
The insulin release stimulated by CCK-'t at its concentration, 10 M 
was 85 ± 8.2 iiU/5 islets/hr, whereas the control value was only 35 ± 3 yU/5 
islets/hr (p<0.001). The CCK-4 stimulated insulin release was found to be 
dose dependent and increased with the concentration of the peptides in the 
incubation medium. This tetrepeptide was found to be active even upto its 
lowest concentration of 10 M where the insulin release was 72 ± 8 yU/5 islets/ 
hr (p<0.001; as compared to control). 
Peptide numbers I, II and III showed no significant insulin releasing 
activity even at their highest concentration of 10 M (Figure 35, p = NS). 
However, peptide numbers IV and V were found to be strong inhibitors 
of insulin release and were effective upto their concentrations ranging from 
10 to 10 M. Their highest inhibitory effect on insulin release was registered 
with their concentration of 10" M. Peptide number IV which caused four fold 
decrease in insulin release was much more potent inhibitor of the release of 
insulin than the peptide number V which exhibited only 3 folds inhibition 
[ (p<0.01); Figure 36]. 
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Fig . 35. Effect of peptides I, II and III on in vitro insulin release. The release 
of insulin by CCK-'f is also shown. The bars represent the mean 
(±S.D.) of-6 experiments. 
*p<0»001 as compared to cont ro l . 
+p = NS as compared to cont ro l . 
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Fig. 36. Effect of peptides IV and V on in vitro insulin release. 
The release of insulin by CCK-'t is also shown simulta-
neously. The bars represent the mean (±S.D.) of 6 expe-
riments. , 
*p<0.001 as compared to control. 
+p<0.01 as compared to peptide IV. 
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Peptide number VI was found to be a potent stimulator of insulin release 
and was active upto a dilution of 10 M. At this concentration, the release 
of insulin was 62 ± 5.2 pU/5 islets/hr (p<0.001; as compared to control). This 
peptide released 133 ± 11.0 ;iU/5 islets/hr of insulin at its concentration of 
10 M showing more than 3 folds stimulation (Figure 37) (p<0.001; as compared 
to 10 M). However, peptide number VI was not as potent stimulator of insulin 
release as the parent molecule CCK-'t which was found to be 5 times more 
effective in releasing insulin than the peptide number VI. 
The data of the insulin release in response to CCK-'f at various peptide 
concentrations is depicted in each figures for comparison. 
4.16 Effect of synthetic analogues of C-terminal tetrapeptide amide of 
cholecystokinin (CCK-4) on glucagon release from islets of Langerhans 
in vitto 
Synthetic analogues of C-terminal tetrapeptide of cholecystokinin were 
tested in vitio for their glucagon releasing activity from isolated islets of 
Langerhans. CCK-'t and its six synthetic analogues were taken for these stu-
dies. 
CCK -4 Trp - Met - Asp - Phe - NH 2 
IA Pro - Met - Asp - Phe - NH-
IIA Glp -Met -Asp -Phe -NH2 
I Phe - Met - Asp -Phe - NH 2 
II Tyr - Met - Asp - Phe - NH 2 
III Trp - Leu - Asp - Phe - NH 2 
IV Trp - Ser - Asp - Me Phe 
V Trp - Met - Asp - Me Phe 
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Fig. 37. Effect of peptide VI in vitro insulin release. The 
release of insulin by CCK-'f is also stiown simulta-
neously. The bars represent the mean ( + S.D.) of 6 
expeniments. 
*p<0.001. as compared to control. 
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Results are presented in Figures 38, 39, 'fO.CLlucagon release wi th CCK-'f 
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at 10 M in the medium was 178 ± 11.5 pg/5 islets/hr whereas the control 
value (without CCK-^) was only 110 ± 8.9 pg/5 islets/hr (p< 0.001). The CCK-i^ 
stimulated glucagon release was dose dependent and increased wi th the con-
centrat ion of the peptides. This tet rapept ide was act ive even at a di lut ion 
of 10" M where it released glucagon from islets in the order of 160 ± 10.4 
pg/5 isiets/hr (p<0.001; as compared to control ) . 
Figure 38 shows that peptide IA and I IA had no signif icant e f fect on 
the release of glucagon even at a concentrat ion of 10 M [the release of glucagon 
was 118 ± 9.2 pg/5 islets/hr and 109 ± 8.1 pg/5 islets/hr in the case of peptide 
lA and I IA respectively, the control value being only 110 ± 8.9 pg/5 islets/hr 
(p =NS)]. 
Peptides 1, II and III showed no signif icant e f fec t on the release of 
glucagon from the islets and the values of the released hormone was found 
to be more or less the same as that of control (p = NS, Figure 39). 
Peptide numbers IV and V which are N-methylated at the C-terminal 
showed inhibi tory ac t iv i ty w i th respect to glucagon release. Here, it can be 
seen from Figure UO that peptide IV is a more potent inhibitor of glucagon 
release, than peptide V and is active upto a di lut ion of 10 M. ^t this d i l u -
t i on , the release of glucagon was only 77 ± 7.5 pg/5 islets/hr whereas the release 
of 110 ± 8.9 pg/5 islets/hr was observed in the case of the control (p<0.001). 
On the other hand, peptide number V was found to be comparat ively 
l e s s i n h i b i t o r y and did not show any antagonistic ac t iv i ty below the con-
centrat ion of 10" M. At this concentrat ion, there was 62 + 6.1 pg/5 islets/hr 
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Fij;. 38. Effect of peptides lA and IIA on in vitro glucagon release. 
The release of glucagon by CCK-'+ is also shown simulta-
, neously. The bars represent the mean (±S.D.) of 6 expe-
riments. 
+p<0.001 as compared to control. 
*p = NS as compared to control. 
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Fig. 39. Effect of pepticles I, II and III on in vitro glucagon release. 
The release of glucagon by CCK-'f is also shown simultaneously. 
The bars represent the mean (±S.D.) of 6 experiments. 
*ip = NS as compared to control. 
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Fig. 'tO. Effect of peptides IV and V on in vitro glucagon release. 
The release of glucagon by CCK-'f is also shown simulta-
neously. The bars represent the mean (±S.D.) of 6 experi-
ments . 
*p<0.001 as compared to control. 
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of glucagon release which was nearly two fold less than that of the control 
value (p<0.001). 
Figure 'fl shows the level of glucagon release by peptide number VI 
which was earlier found to be stimulatory for insulin release. This compound 
has been found to be inhibitory for glucagon release and the inhibition of glu-
cagon release by this peptide was observed upto its dilution of 10 M. At 
this concentration the glucagon release was 85 ± 6.8 pg/5 islets/hr which was 
about 1.2 fold less than that of the control (p<0.01). With this peptide, highest 
inhibition of glucagon release was observed at the concentration of 10 , regis-
tering a 1.6 fold decrease in the release of glucagon (p< 0.001). 
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Fig. 1^1. Effect of peptide VI on in vitro gJucagon release. The 
release of glucagon by CCK Jf is also shown simultane-
ously. The bars represent the mean { + S.D.) of 6 experi 
ments . 
*p<O.Ol as compared to control. 
**p<0.001 as co;npared to control. 
5,0 DISCUSSION 
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5.1 Studies on the factors affecting the diminished insulin release during Aging, 
mediated by Agaricus bisporus PH A-B lectin from islets of Langerhans in 
vitro 
The present studies indicate that there is a definite correlation between 
the binding of the Agaricus bisporus lectin (PHA-B) and the associated events 
in the islet cells leading to the stimulated release of insulin. The release of other 
peptide hormones of the islet have not been studied by us. The effect of partially 
purified fraction of A. bisporus PHA-B on insulin and glucagon release heis been 
demonstrated by Ewart et ai. (1975). They have shown that out of the two fra-
ctions of this lectin, only PHA-B can stimulate the secretion of islet hormones 
while the PHA-A fraction has no effect on the islet cell with respect to the 
secretion of the peptide hormones. 
Ahmad et al. (198'fb) using a purified preparation of the PH A-6 fraction 
of the lectin have reported its effect on the release of insulin and the uptake 
of Ca on the isolated islets of langerhans from different age groups of rat. 
They have shown that age has a significant inhibitory effect on the efficiency 
of the B-cell to release insulin and also to incorporate '^ ^Ca '^*". 
U S 
125 Our results show that the binding of the I4ec t in on the islet cells is 
related to the age of the animal. Thus, as shown in the results, the binding of 
the lect in t o the islet cells decreases w i th the increase of age of the animal . 
When we examine the pat tern of the release of insulin from the islets of langer-
hans isolated from di f ferent age groups of ra t , in the l ight of the binding pat tern 
of the lect in t o the islets of d i f ferent age groups of ra t , we f ind a def in i te co r re -
lat ion between the binding of the lect in and the consequent st imulat ion of insulin 
release. The isolated islets from older rats do not release insul in, as repidly as 
do islets f rom younger ones (Reaven et a l . , 1980; Sawa and Friesen, 1969). This 
slower response occurs despite the fact that islets from old rats are larger and 
contain more beta cel ls, and that each beta cel l appears to store more insulin 
than beta cells from young rats (Reaven et a l . , 1980). From the results presented 
here, it would appear that basal insulin secretion at 2 m M glucose does not alter 
w i th the age of the ra t . This is in agreement wi th the f inding of Lipson et a l . 
(1981a). However, when A. bisporus PHA-B was added to the medium, the basal 
insulin release was enhanced and the e f fec t of age on insulin release was quite 
s igni f icant. These results confirm the eeirlier f inding of Ahmad et a l . (198'fb). 
This ef fect of lect in can also be correlated w i th i ts binding on B-cell membrane. 
The changes of the B-cell membrane wi th aging, e f fec t ing the binding of various 
secretagogues may be one of the major causes of ma tu r i t y onset Diabetes mellitus. 
The FHA-B lect in has been employed in the present studies since this lect in and 
that from A. capestris are the only two lect ins known t i l l now, which cause a 
signif icant increase in the rate of both insulin and glucagon release from pancrea-
t i c islets of langerhans. The other pecu l ia r i ty of this lect in st imulated insulin 
release is its lack of energy dependence (Ewart et a l . , 1975). Insulin secretion 
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is known to be energy dependent (Coore and Randle, 196'f). It is now well known 
that glucose, in addition to furnishing the signal for insulin secretion, also acts as 
a substrate for the provision of energy required for the secretory process. Since 
the effect of A. bisporus PHA-B in stimulating insulin release were routinely t e s -
ted in the presence of low glucose concentration (2 mM), it seems possible that 
the enhanced stimulatory effect of the lectin represented a minimum estimate 
because of low availability of substrate for energy generation by B-cells. Ewart 
et al. (1975) have, however, demonstrated that there was no potentiation of the 
A. bisporus FWA-B stimulation of insulin releeise in the presence of 5.6 mM glu-
cose. To further test whether an additional energy source might lead to an increa-
sed stimulation of insulin release by the lectin, Ewart et al. (1975) showed that 
10 mM sodium pyruvate, an energy substrate for the B-cell caused a significant 
stimulation of basal insulin release while A. bisporus PHA-B and glucose stimulated 
insulin release were not affected. It was concluded that lectin effect could not 
be enhanced by provision of additional energy. The same authors have also repor-
ted that 2,'f-dinitrophenol, an uncoupler of oxidative phosphorylation at a concen-
tration of 250 mM was without effect on insulin release in the presence of 2 
mM glucose and 2 mM glucose + 17.5 yg/ml A. bisporus PHA-B lectin, while glu-
cose stimulated insulin secretion wcis abolished by the agent. In view of these 
findings, it may be concluded that the lectin PHA-B stimulated release of islet 
hormones is due to its action on the cell membrane. The similarity in the con-
centration dependent curves for the lectin binding and for the stimulation of 
insulin release by the lectin presented here strongly implies that binding to the 
islet cell surface is a prerequisite for the expression of activity. The mechanism 
of lectin PHA-B stimulated insulin release may be explained by accepting the 
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membrane site of action for the lectin. It is conceivable, therefore, that PHA-B 
lectin induces alterations in the structure or arrangement of specific membrane 
components resulting accelerated insulin release. Ewart et al. (1975) concluded 
that this lectin effect does not fulfil the usually accepted criteria for true secre-
tory process. They further investigated the influence of lectin binding on other 
metcibolic function of the islets. No islet cell damage by the lectin could be detec-
ted. They have reported that A. bisporus PHA-B lectin at a concentration that 
produces hcilf maximal stimulation of insulin release (17.5 yg/ml) did not effect 
3 
the rate of islet incorporation of H-labelled leucine into TCA precipitable protein 
or the rate of islet metcibolism of glucose or CO_. Our results on the incorpora-
tion of C-leucine into islet protein, however, show that there is a significant 
stimulation of C-leucine into the proinsulin in the presence of PHA-B lectin 
at its concentration of 30yg/ml and the biosynthesis of proinsulin is almost com-
pletely inhibited by cycloheximide. The stimulation of insulin biosynthesis in the 
one month old rats was found to be about 3.7 times higher than in the case of 
12 month old rats. When PHA-B (30 yg/ml) was added to the medium, the st i-
mulation of proinsulin biosynthesis was found to be 3 times in the case of one 
month old rats, while in the case of 12 months old rats the stimulation of pro-
insulin biosynthesis due to the lectin was only about 1.5 times. The effect of 
lectin PHA-B on other metabolic function of islet, as shown in the results, is 
also quite evident. Thus (i) there is about 20.7 times more uptake of Ca "^  
in the case of islet of one month old rats when incubated with PHA-B lectin. 
There was constant decrease in the stimulatory effect of the lectin to Ca "^  
uptake with the advancing age of the animal. Thus, in the case of 12 months 
old rats, there is only about 5 times more uptake of Ca into the islet when 
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incubated with the lectin. In the control experiment (without lectin), there is 
tt5 2+ 
no significant difference in the uptake of Ca into the islets of different age 
groups of rats, (ii) the activity of lysosomal enzyme cathepsin-B of islets which 
has been reported to increase in the presence of insulin secret agogues, also show 
a significant increase in the presence of PH A-B lectin. The activity of acid phos-
phatcise seems not to be affected by this lectin. However, the activity of protein 
kinase, does not seem to be effected by the lectin or by the age of the animal, 
(iii) The effect of the lectin binding on the content of proinsulin and insulin in 
the islet have been determined as a measure for the conversion of proinsulin to 
insulin in different age groups of rats. Our results clearly show that the trans-
formation of proinsulin is more pronounced in the case of one month old rat, where 
the ratio of proinsulin to insulin is 1:3 while in the case of 12 month old rat the 
ratio of proinsulin to insulin is 1:1.3. These results indicate that the binding of 
lectin PH A-B on the beta cell membrane triggers some metabolic event of the 
cells. These findings are contradictory to the assumption of Ewart et al. (1975) 
that lectin binding per se, even to the appropriate receptor, is not itself sufficient 
to evoke the islet response. The nature of the lectin receptor on the islet cells 
membranes has not yet been determined. Our results, however, show that the 
receptor is, probably, different from that of glucose receptor since the binding 
of the lectin at its receptor is not reversed by increasing the concentration of 
glucose in the medium. 
Aging may be one of the factors for the alteration of the composition 
of beta cell membrane and the arrangement of the membrane components. This 
may result in the reduced binding of the secretagogue to the B-cell membrane 
of the older animals compared to its binding on the beta cell membrane of younger 
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animals. The binding of the lectin may induce further rearrangement of the 
membrane components resulting in the comparatively increased rate of insulin 
secretion or the facilitation in the uptake of Ca as reported by Ahmad et 
al. (198'»b) and dso presented in this dissertation. The stimulation in the uptake 
of C-leucine into the islet protein by PHA-B lectin and the stimulation of pro-
insulin converting enzyme resulting in increased conversion of proinsulin to insulin, 
shown in this dissertation may also be explained in the same way. 
5.2 Biochemical studies on the hypoglycemic properties of Pterocarpus 
marsupiiiin Roxb. 
Our results clearly demonstrate that oral feeding of ethyl acetate soluble 
fraction of alcoholic extract of the bark of Pterocarpus marsupium (XE) to allo-
xan diabetic rats significantly brings down their blood glucose level. Thus, the 
blood glucose level in the caise of alloxan diabetic rats comes down from 337 mg/di 
to 98 mg/dl after 5 days of oral feeding of the plant extract. These results support 
the findings of Chakravarthy et al. (1980) who demonstrated the protective effect 
of this plant extract against alloxan toxicity when administered intraperitoneally 
to rats prior to the administration of alloxan. These authors have ciiso reported 
the increase of B-cell population of the pancreas in the alloxan diabetic rats which 
administered XE prior to the administration of alloxan. In our oral feeding expe-
riments, however, we could not find any difference in the B-cell population of 
the pancreas taken from normal animals with or without the prior feeding of the 
plant extract. Neither could we find any significant difference in the rate of 
regeneration of B-cells in the alloxan diabetic rats which were fed with the drug 
for 5 days (data not presented). Chakravarthy et ai. (1980) could not find any 
significant effect of XE on bJood sugar level of normal albino rats but they reported 
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consistent e f fec t of XE in alloxan hyperglycemic animal in which the blood sugar 
lowering e f fec t of XE was quite s igni f icant . 
The results of our feeding experiments show that the administrat ion of 
the drug prior t o al loxan, is not important for the reversal of alloxan t ox i c i t y 
since our results c lear ly demonstrate that the 5 days feeding of XE after alloxan 
administrat ion brings back the blood glucose level of the alloxan diabet ic rats 
t o the almost nonmeil leve l . The inconsistent e f fec t of XE on the blood glucose 
level of normal rats as reported by Chakravarthy et a l . (1980) may be due t o the 
other factors which along wi th insulin are responsible for glucose homeostasis 
in normal animals. The data presented here on the ef fect of XE on glucose t o l e -
rance test carr ied out on edloxan diabet ic rats w i th and without the oral feeding 
of XE, leaves no doubt about its protect ion against cilloxan tox i c i t y . 
Chakravarthy et a l . (1981) have also isolated the act ive pr inciple (-) Ep i -
catechin, a f lavanoid which signi f icant ly protects the islets against alloxan 
tox i c i t y and also st imulate the regeneration of B-cells in alloxan diabetic rats 
when administered intraperi toneal ly prior t o al loxan. Kolb et a l . (1982) have, 
however, reported contrary results on the ac t i v i t y of (-) Epicatechin. They fa i led 
t o reproduce the results of Chakravarthy et a l . (1981) and reported that (-) Ep i -
catechin had no e f fec t on B-cell regeneration in the edloxan diabetic rats. They 
could not also reproduce the findings of Chakravarthy et a l . (1981) on the p ro tec -
t ion of B-cell by epicatechin against alloxan tox i c i t y . Our results and also the 
results of Charles et a l . (198't) strongly support Chakravarthy et a l . (1980) 
findings about antihyperglycemic ef fect of XE. Our in v i t ro studies, presented 
here clearly demonstrate the insulinogenic proper ty of (-) Epicatechin. The 
in vitro st imulat ion of phosphofructokinase and inhibi t ion of glucose-6-phosphatase 
12it 
in the islets by epicatechin may also be taken as an indirect evidence of the 
effect of epicatechin on the increased biosynthesis of insulin. Our feeding 
studies demonstrate its in vivo hypoglycemic effect in alloxan diabetic rats. 
Charles et al. (198'^) have also reported their findings which support Chakravarthy's 
original findings. They have shown that the increase in the insulin secretion 
mediated by (-) Epicatechin is both ATP and temperature dependent. These 
authors suggested that (-) Epicatechin could have direct effect on the islets 
of langerhans in vitro and showed that (-) epicatechin also increased DNA synthe-
sis in islets culture for four days. Our results presented here, on the incorpora-
tion of C4eucine into (pro)msulin when the islets from alloxan diabetic rats, 
with and without the orad feeding of epicatechin, was isolated and in vitro 
Ik incorporation of C-leucine was studied. From these results, it is clear that 
(-)epicatechin feeding to alloxan diabetic rats increases protein biosynthesis 
in islets in general and reverses the adloxan toxicity in the B-cells which is 
evident from the increased incorporation of C-leucine into (pro)insulin. These 
results together with the findings of Charles et al. (198^ )^ about the effect of 
epicatechin on the DNA synthesis suggest the possibility that the reported B-
cell regeneration brought about by epicatechin administration after the alloxan 
treatment may be a direct effect on B-cell replication. 
Inhibition of cAMP phosphodiesterase by flavanoids has been reported 
by Ferrel et al. (1979) and specific inhibition of this enzyme extracted from 
cardiac muscle by epicatechin is also reported (Beretz, 1978). 
In view of our results on stimulation of (pro)insulin biosynthesis by epi-
catechin and the findings reported by Charles et al. (198^*) it is conceivable 
that at least sOiTie of the effect of epicatechin on islets function is via cAMP 
system. 
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Though the chemical structure of (-)epicatechin is quite different from 
earlier reported hydroxyl radical scavengers, its role in nullifying the diabetogenic 
action of alloxan by acting as hydroxyl radical scavenger cannot be ruled out. 
53 Structure activity relationship of CCK-4 and its analogues with respect 
to insulin and glucagon release from the islets of Langerhans in vitro 
Our results indicate that structural modification in the C^erminal t e t ra -
peptide amide of cholecystoi<inin CCK-'f may lead to the development of such 
analogues of CCK-^ w h^ich may selectively release the desired hormone(s) from 
the islets of Langerhans without effecting the release of the other islet hormones 
or may act as inhibitor for the release of certain islet hormones and at the 
same time stimulator for the release of other hormone(s). This possibility of 
introducing selectivity in the otherwise nonspecific releaser of islet hormones 
is highly significant in the sense that it forms the basis of an entirely new app-
roach for designing molecules which may prove to be of clinical value for the 
treatment of Diabetes mellitus. As shown in the results, presented in this disser-
tation, the replacement of a single amino acid at position I of CCK-'f has intro-
duced specificity in the CCK-'t molecule with respect to the release of peptide 
hormones, from the islets. The replacement of the first amino acid Trp by 
other aromatic amino acids such as Phe (I), Tyr (II) resulted in loss of stimulatory 
activity of CCK-'t with respect to the release of insulin and glucagon from the 
islets of Langerhans in vitro. On the other hand, the substitution of Tryptophan 
at position one by cyclic amino acid pro (lA) or Gip (IIA) retains the insulin 
releasing activity of the molecule. One may infer from these observations that 
the aromatic nature of the first amino acid is not necessary for the insulin relea-
sing activity of the molecule. On the other hand, the stimulation of glucagon 
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releasing activity of these two analogues is almost completely abolished. 
Examining different molecular forms of CCK, Rehfeld et al. (1980) 
concluded that intact tetrapeptide amide was necessary for the hormonal peptides 
releasing activity from the islets. They showed that NH--terminal modification 
such as removal of Tryptophan (CCK-3), extension by Glycine (CCK-5) or by 
Boc-6-alanine, greatly reduced the secretagogue activity of the analogues. 
Our results and also the results of Ahmad et al. (198't) from this laboratory 
clearly show that insulin releasing activity although reduced is still retained 
even by the modification of Tryptophan at position I. Thus, the activity profile 
of these two analogues lA and IIA suggest that the N-terminal Trp is not essen-
tial for the biological activity per se. Its other functions, such as involvement 
in the receptor binding cannot be, however, ruled out. The replacement of 
the first amino acid Trp by other aromatic anino acids such as Phe (I) or Tyr 
(II) resulted in the loss of the stimulatory activity for both insulin and glucagon, 
although, as discussed above, the replacement by other cyclic amino acid at 
position one (pro and glp) in place of Trp retain the insulin releasing activity 
selectively having no effect on the releeise of glucagon. Replacement of methi-
onine at position two by hydrophobic amino acid (leucine) and hydrophilic amino 
acid (serine) yielded analogues III and IV, respectively. The analogue III with 
leucine at position two has no effect on the release of two hormones, insulin 
and glucagon. The other analogue with hydrophilic amino acid (serine) at posi-
tion II shows no effect in its diluted form, however, at its higher concentration 
in the medium above 10~ M it shows its inhibitory effect on both, the release 
of insulin and glucagon, thereby suggesting that methionine residue at position 
II is necessary for its activity as secretagogue. Rehfeld et al. (1980) have shown 
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that C-terminal modification of CCK-t^ also reduces its potency. In the present 
studies, the peptide bond between Asp-Phe has been modified (peptide IV and V). 
Methylation of this internal amide bond resulted in the inhibition of both insulin 
as well as glucagon secretion. This observation provides further support to the 
earlier observation of Rehfeld et al. (1980) that slight change at Cterminal would 
result in loss of CCK-'t like activity. 
Introduction of double modification in the CCK-'t, i.e. Trp at position one 
replaced by pro and the methylation of C^erminal amide yielded a most interesting 
compound having desired activity profile. The new analogue Pro - Met - Asp -
Phe -NHCH, (VI) stimulates the secretion of insulin and at the same time inhibits 
the secretion of glucagon in a dose dependent manner. Although the stimulatory 
effect of this analogue on the release of insulin is not as strong as that of CCK-'t 
itself, the remcirkcible improvement in the activity profile has been the selective 
stimulation of insulin with concomitant inhibition of the release of glucagon. In 
this respect, this dual activity of this aneilogue makes it closer to glucose, which 
is the neutral physiological factor for the control of the release of hormonal 
peptide from the islets and, therefore, this aneilogue needs further detailed studies 
with the view to developing a new drug for the control of diabetes mellitus. 
6 . 0 SUMMARY AND CONCLUSIONS 
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Trie endocrine part of the mammal ian pancreas is composed of small 
clusters of cells, the islets of Lc^ngerhans, i r regular ly distr ibuted in the pancrea-
t i c parenchyma. Although more than hundred years have passed since the f i rs t 
description of the pancreatic islets by Paul Langerhans, our knowledge of the i r 
cellular composition is st i l l incomplete. It appears that there are at least four 
types of cellular populations in the islets, each responsible for the synthesis, s to -
rage and release of its specif ic peptide hormone according t o the need. Str ict 
regulation of the release of these d i f ferent types of pancreat ic hormones is vital 
since the int r icate balance of these hormones play a very important role in m a i n -
ta in ing a proper metabol ic order in animals. 
Abnormalit ies in beta cell s t ructure and funct ion may be et io logical ly 
involved in the expression of diabetes mellitus. Many diverse abnormalit ies in 
beta cell integri t ies may result in a c l in ical syndrome characterized by carbohy-
drate intolerance. In the present studies, e f for ts have been made to gain some 
knowledge on the changes in the beta-ce l l , due to age as indicated by the binding 
of certain insulin secretagogues on the islets isolated from di f ferent age groups 
of rats. The correlation between the binding of insulin secretagogues and the 
result ing islets act iv i t ies have been studied. In addit ion, insulin releasing ac t iv i ty 
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of certain plant material as well as synthetic compounds have been described 
in this dissertation. The results cind conclusion are summarized. 
6.1 Studies on the factors affecting the diminished insulin release during aging, 
mediated by Agaricus bisporus PH A-B lelctin from islets of Langerhans in 
vitro 
125 6.1.1 Effect of age on the binding of I-lectin to islets of Langerhans in 
vitro 
The binding studies were carried out in vitro on the isolated islets of 
125 Langerhans. There was nearly three fold decrease in the binding of 1-lectin 
in the case of islets from 12 months old rats as compared to that from one month 
old rats. Thus, the binding of the lectin in the case of the islets isolated from 
1, 3, 6 and 12 months old rats were 22.ifl ± 2.f 1, 17.12 ± 2.21, 11.80 ± 2.02 and 
7.51 ± 1.81 ng of lectin bound/15 islets respectively, showing the age related 
changes on the beta-cell membrane effecting the binding of the lectin. 
125 6.1.2 Effect of glucose on the binding of I-team (PHA-B) to the islets 
in vitro 
There was no significant change in the binding of lectin to islets in the 
presence of increasing concentration of glucose in the medium indicating that 
the binding sites of glucose and the lectin might be different. 
6.1.3 Effect of the binding of PHA-6 lectin on lysosomal enzymes 
While the Cathepsin-B activity increased significantly after the binding 
of lectin to the islet in a dose dependent manner, there was no effect of the 
lectin on the activity of acid phosphatase. The stimulation of cathepsin-B by 
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different insulin secretagogues have been shown by many workers which suggested 
the involvement of cathepsin-B in the conversion of proinsulin to insulin. 
6.1 A Effect of the lectin binding on the islet on protein kinase activity 
Age has been found to have no effect on the activity of protein kinase, 
neither has lectin (PHA-B) any effect on the activity of this enzyme indicating 
that protein kinase activity might not be involved in the changes in the islets 
due to age. 
6.1.5 I Effect of age on Aqaricas bisporus PHA-B stimulated insulin release 
There was significant stimulation of insulin release with sub-optimal glu-
cose concentration in the medium, when PHA-B lectin was added. This stimula-
tion of insulin release constantly decreased with age. This confirmed the earlier 
findings and can be correlated with the corresponding decreasing binding of the 
lectin to the islets with the increasing age of the animal. 
6.1.6 Effect of age on Aqaricus bisporus MA-B stimulated Ca uptake 
Like insulin release there was significant increaise in the uptake of Ca 
with sub-optimal glucose concentration when PHA-B lectin was added in the 
k5 2+ 
medium. The stimulation of Ca uptake with the lectin decreased constantly 
with the increasing age. This might also be the result of the binding of the lectin 
to the B-cell. 
6.1.7 Effect of age on proinsulin/insulin content and Cleucine incorporation 
into the (pro)insulin in the isolated islets of Langerhans 
In the older age groups of rats (12 months) the content of proinsulin/insulin 
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was found to be about two times higher than in case of one month old rat. 
However, the stimulation of proinsulin biosynthesis by the PHA-B lectin was 
more than three times higher in the case of the islets from one month old rat 
than that of the 12 months old rats. The above observations were supported 
[if. 
by the direct incorporation of C4eucine into proinsulin in vitro in the islets 
of both the groups of rats. It was found that there was two times more incor 
14 poration of C-leucine in the case of islets isolated from one month old rats 
than in the case of islets of 12 months old rats after the stimulation by the 
lectin. 
6.1.8 Effect of age on the lectin (PHA-6) stimulated conversion of proinsulin 
to insulin 
Proinsulin cind insulin of the islets were separated by sephadex G-50 fil-
tration. Proinsulin was characterized by its conversion to insulin by trypsin. 
Insulin was estimated by the radioimmunoassay, technique. PHA-6 lectin stimu-
lated the conversion of proinsulin to insulin quite significantly. It was found 
that age has a pronounced effect on the lectin mediated transformation of pro-
insulin. The conversion of proinsulin to insulin in the case of 12 months old 
rats was found to be about 14% less as compared to the conversion in the case 
of one month old rats. It was concluded that the conversion of proinsulin to 
insulin might be an important step in the release of insulin from the islets. 
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6 .2 Biochemical studies on the hypo^ycemic properties of Pterocarpus marsu-
pium Roxb. 
6.2.1 Effect of (-) Epicatechin on insulin release from the islets of Langerhans 
in vitro 
It was found that (-)epicatechin stimulates insulih secretion from isolated 
islets of Langerhans in a dose dependent manner quite significantly. (-) Epicate-
chin is the active principle of the water extract of the wood of Pterocarpus 
marsupium. The claim of hypoglycemic activity in the water extract of the 
wood was confirmed. 
6.2.2 Effect of (-)epicatechin on the activities of glucose-6-phosphatase and 
phosphofructoi<inase in islets of Langerhans in vitro 
In vitro studies on isolated islets of Langerhans showed that (-)epicatechin 
significantly diminished the activity of glucose-6-phosphatase, while the activity 
of phosphofructokinase was significantly increased. These findings further suppor-
ted the hypoglycemic property of the wood extract. 
6.2.3 Effect of (-)epicatechin on C4eucine incorporation into (pro)insulin 
in islets of Langerhans in vitro 
The stimulation of proinsulin biosynthesis by (-)epicatechin was demons-
trated by the significant incorporation of C-ieucine into promsulin when the 
islets were incubated in vitro with (-)epicatechin. The incorporation of C-
leucine was found to be dependent on (-)epicatechin concentration in the medium. 
Cycloheximide was found to completely block the (-)epicatechin stimulated pro-
insulin biosynthesis in the islets. These observations further support that the 
plant possesses the property of stimulating insulin biosynthesis. 
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6.2.'f Studies on the hypoglycemic properties of wood extract of Pterocarpus 
marsupium Roxb. 
The feeding of ethyl acetate soluble fraction (XE) of alcoholic extract 
of Pterocarpus marsupium wood to alloxan induced diabetic rats was found to 
have a significant effect of lowering the fasting blood sugar level. Glucose 
tolerance test carried out on the cilloxan diabetic rats which were fed with 
the wood extract showed a marked improvement in their blood glucose lowering 
capacity. These findings support the claim that the extract of Pterocarpus 
marsupium wood is effective for the control of diabetes mellitus. 
There was also significant increase in the insulin level of the blood in 
case of alloxan diabetic animals which were fed with the extract, compared 
to the control animals (alloxan diabetic without drug treatment). 
[tj. 
The stimulation of the incorporation of C-!eucine into (pro)insulin fra-
ction in the case of XE fed animals, suggest that the extract XE is not only 
insulinogenic but also stimulates the biosynthesis of insulin. 
6.3 Effect of synthetic analogues of C-tenninal tetrapeptide amide of chole-
cystokinin on insulin and glucc^on release from the islets of Langerhans 
in \itro 
C-terminal tetrapeptide amide of cholecystokinin (CCK-^) and eight 
of its synthetic analogues were tested on isolated islets of Langerhans for their 
glucagon and insulin releasing activity. Synthetic cholecystokinin (CCK-^) was 
found to be highly active in releasing both insulin and glucagon from the isolated 
islets of Langerhans. It was found to be active for the release of both the 
hormones upto its concentration of 10" M. The stimulation of release of both 
m 
the hormones by CCK-'f was found to be dose dependent. Eight analogues of 
CCKJf were tested for their effect on the release of insulin and glucagon. 
It was found that the replacement of the first amino acid Trp by other aroma-
tic amino acids such as Phe or Tyr makes the compound ineffective for the 
release of both insulin or glucagon. However, the substitution of Trp at position 
one by pro or Glp does not effect much on their insulin releasing capacity. 
On the other hand, the glucagon releasing activity of these two analogues is 
almost completely lost. Replacement of methionine at position two by hydrop-
hobic amino acids (leucine) and hydrophilic amino acid (serine). The analogue 
with leucine at position two had no effect on the release of two hormones. 
The other analogue with serine -at position two showed inhibitory effect on the 
release of both insulin and glucagon. Methylation of the internal amide bond 
between Asp-Phe resulted in the inhibition of both insulin and glucagon secre-
tion. Introduction of double modification in the CCK-'f molecule, i.e. the repla-
cement of Trp at position one by pro and the methylation of C-terminail amide, 
yielded a compound which stimulated insulin release and at the same time inhibits 
the release of glucagon in a dose dependent manner. 
Thus, it is clear that useful compound with clinical importance can be 
obtained from the CCK-'f analogue for the development of drugs for the control 
of the type II diabetes melUtus. 
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